If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> including biology and use of blood stem cells<br /> Volume 50 Supplement 1 March 2015 www.nature.com/bmt<br /> The official journal of the European Society for Blood and Marrow Transplantation<br /> Welcome Address<br /> Welcome Address from the Local Committee<br /> Dear Friends,<br /> On behalf of the EBMT 2015 Local Organising Committee, it is<br /> our pleasure to welcome you to the 41st EBMT Annual<br /> Meeting, including the 31st Meeting of the EBMT Nurses Group,<br /> the 14th Meeting of the EBMT Data Management Group, the<br /> 7th Meeting of the Quality Management Group, and the 9th<br /> EBMT Patient & Family Day.<br /> The Scientific Programme includes symposia and educational<br /> sessions related to the specific problems of stem cell<br /> transplantation and the indications for transplantation.<br /> The EBMT Nurses Group <a title="EBMT Annual Meeting 2015 Absract Book page 1" href="http://viewer.zmags.com/publication/b0929dae?page=1"> </a> <a title="EBMT Annual Meeting 2015 Absract Book page 2" href="http://viewer.zmags.com/publication/b0929dae?page=2"> Welcome Address Welcome Address from the Local C</a> <a title="EBMT Annual Meeting 2015 Absract Book page 3" href="http://viewer.zmags.com/publication/b0929dae?page=3"> Organising Committee Congress co-Presidents Tan</a> <a title="EBMT Annual Meeting 2015 Absract Book page 4" href="http://viewer.zmags.com/publication/b0929dae?page=4"> EBMT Lectures 1998–2015 1998 Treating CML: pres</a> <a title="EBMT Annual Meeting 2015 Absract Book page 5" href="http://viewer.zmags.com/publication/b0929dae?page=5"> Van Bekkum Awards 1998–2015 1998 Induction of a</a> <a title="EBMT Annual Meeting 2015 Absract Book page 6" href="http://viewer.zmags.com/publication/b0929dae?page=6"> 2007 Single nucleotide polymorphisms of the NOD2/</a> <a title="EBMT Annual Meeting 2015 Absract Book page 7" href="http://viewer.zmags.com/publication/b0929dae?page=7"> 2014 T Cells engineered with a chimeric antigen r</a> <a title="EBMT Annual Meeting 2015 Absract Book page 8" href="http://viewer.zmags.com/publication/b0929dae?page=8"> Reviewers We would like to thank the following</a> <a title="EBMT Annual Meeting 2015 Absract Book page 9" href="http://viewer.zmags.com/publication/b0929dae?page=9"> March 2015 </a> <a title="EBMT Annual Meeting 2015 Absract Book page 10" href="http://viewer.zmags.com/publication/b0929dae?page=10"> PHYSICIANS POSTER SESSIONS/DAY 2 Cell therapy/cel</a> <a title="EBMT Annual Meeting 2015 Absract Book page 11" href="http://viewer.zmags.com/publication/b0929dae?page=11"> PHYSICIANS ABSTRACTS Van Bekkum Award O0</a> <a title="EBMT Annual Meeting 2015 Absract Book page 12" href="http://viewer.zmags.com/publication/b0929dae?page=12"> Basic Science Award O002 Exploring Limiting Fa</a> <a title="EBMT Annual Meeting 2015 Absract Book page 13" href="http://viewer.zmags.com/publication/b0929dae?page=13"> Unit, Ospedali Riuniti Villa Sofia-Cervello, Paler</a> <a title="EBMT Annual Meeting 2015 Absract Book page 14" href="http://viewer.zmags.com/publication/b0929dae?page=14"> of an allograft and lacking a standard donor. To </a> <a title="EBMT Annual Meeting 2015 Absract Book page 15" href="http://viewer.zmags.com/publication/b0929dae?page=15"> O006 RIC vs. MAC followed by allogeneic stem cell</a> <a title="EBMT Annual Meeting 2015 Absract Book page 16" href="http://viewer.zmags.com/publication/b0929dae?page=16"> including 12 pediatric/adolescent cases o18 years</a> <a title="EBMT Annual Meeting 2015 Absract Book page 17" href="http://viewer.zmags.com/publication/b0929dae?page=17"> Oral session: Acute leukemia 1 O009 Activity o</a> <a title="EBMT Annual Meeting 2015 Absract Book page 18" href="http://viewer.zmags.com/publication/b0929dae?page=18"> II-IV acute graft-versus-host disease, nor t</a> <a title="EBMT Annual Meeting 2015 Absract Book page 19" href="http://viewer.zmags.com/publication/b0929dae?page=19"> to the reduced incidence of NRM with no significan</a> <a title="EBMT Annual Meeting 2015 Absract Book page 20" href="http://viewer.zmags.com/publication/b0929dae?page=20"> Grade II-IV acute GVHD was 26% vs 30% (P ¼ 0.11) </a> <a title="EBMT Annual Meeting 2015 Absract Book page 21" href="http://viewer.zmags.com/publication/b0929dae?page=21"> 599 days (range, 55-2538 days). WT1 MRD mon</a> <a title="EBMT Annual Meeting 2015 Absract Book page 22" href="http://viewer.zmags.com/publication/b0929dae?page=22"> myeloablative Busulfan based strategies in t</a> <a title="EBMT Annual Meeting 2015 Absract Book page 23" href="http://viewer.zmags.com/publication/b0929dae?page=23"> 64y) received ivBu. In the TBI group 76 pts suffe</a> <a title="EBMT Annual Meeting 2015 Absract Book page 24" href="http://viewer.zmags.com/publication/b0929dae?page=24"> either with a thiotepa-based chemotherapy (n ¼ 12</a> <a title="EBMT Annual Meeting 2015 Absract Book page 25" href="http://viewer.zmags.com/publication/b0929dae?page=25"> cumulative incidence of relapse (CIR) stratified b</a> <a title="EBMT Annual Meeting 2015 Absract Book page 26" href="http://viewer.zmags.com/publication/b0929dae?page=26"> As measured from alloSCT prior to DLI BM progress</a> <a title="EBMT Annual Meeting 2015 Absract Book page 27" href="http://viewer.zmags.com/publication/b0929dae?page=27"> associated with worse outcome were disease </a> <a title="EBMT Annual Meeting 2015 Absract Book page 28" href="http://viewer.zmags.com/publication/b0929dae?page=28"> O029 Blood graft cellular composition and early p</a> <a title="EBMT Annual Meeting 2015 Absract Book page 29" href="http://viewer.zmags.com/publication/b0929dae?page=29"> (PETo3.35). Response to high dose Melph</a> <a title="EBMT Annual Meeting 2015 Absract Book page 30" href="http://viewer.zmags.com/publication/b0929dae?page=30"> patients (pts); however, in the ``new drugs era''</a> <a title="EBMT Annual Meeting 2015 Absract Book page 31" href="http://viewer.zmags.com/publication/b0929dae?page=31"> Disclosure of Interest: R. Gam Funding from: This</a> <a title="EBMT Annual Meeting 2015 Absract Book page 32" href="http://viewer.zmags.com/publication/b0929dae?page=32"> reconstitution and a complete control of GvHD, pr</a> <a title="EBMT Annual Meeting 2015 Absract Book page 33" href="http://viewer.zmags.com/publication/b0929dae?page=33"> three cohorts but approached 100% in patien</a> <a title="EBMT Annual Meeting 2015 Absract Book page 34" href="http://viewer.zmags.com/publication/b0929dae?page=34"> 21%, 32% and 29%of the patients.These different r</a> <a title="EBMT Annual Meeting 2015 Absract Book page 35" href="http://viewer.zmags.com/publication/b0929dae?page=35"> MAC or RIC based on published criteria. Th</a> <a title="EBMT Annual Meeting 2015 Absract Book page 36" href="http://viewer.zmags.com/publication/b0929dae?page=36"> Results: 3-year OS was 33,3%. Ptso9y.o. had</a> <a title="EBMT Annual Meeting 2015 Absract Book page 37" href="http://viewer.zmags.com/publication/b0929dae?page=37"> pulsed DCs. Mothers also possessed CD4 T c</a> <a title="EBMT Annual Meeting 2015 Absract Book page 38" href="http://viewer.zmags.com/publication/b0929dae?page=38"> 2. Wang Y, et al. Long-term follow-up of </a> <a title="EBMT Annual Meeting 2015 Absract Book page 39" href="http://viewer.zmags.com/publication/b0929dae?page=39"> of understanding of the physical and psychosocial</a> <a title="EBMT Annual Meeting 2015 Absract Book page 40" href="http://viewer.zmags.com/publication/b0929dae?page=40"> Conclusion: The observed mortality rate was 40% f</a> <a title="EBMT Annual Meeting 2015 Absract Book page 41" href="http://viewer.zmags.com/publication/b0929dae?page=41"> colonization in one or more surveillance sw</a> <a title="EBMT Annual Meeting 2015 Absract Book page 42" href="http://viewer.zmags.com/publication/b0929dae?page=42"> pertussis, Bordedella parapertussis, Legion</a> <a title="EBMT Annual Meeting 2015 Absract Book page 43" href="http://viewer.zmags.com/publication/b0929dae?page=43"> from 2000 to 2012 for acute leukaemia, recorded i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 44" href="http://viewer.zmags.com/publication/b0929dae?page=44"> [O057] Materials (o</a> <a title="EBMT Annual Meeting 2015 Absract Book page 45" href="http://viewer.zmags.com/publication/b0929dae?page=45"> Materials (or patients) and methods: The or</a> <a title="EBMT Annual Meeting 2015 Absract Book page 46" href="http://viewer.zmags.com/publication/b0929dae?page=46"> O060 Validation of two new prognostic scores to p</a> <a title="EBMT Annual Meeting 2015 Absract Book page 47" href="http://viewer.zmags.com/publication/b0929dae?page=47"> graft-versus-host disease (aGVHD) and non-relapse</a> <a title="EBMT Annual Meeting 2015 Absract Book page 48" href="http://viewer.zmags.com/publication/b0929dae?page=48"> Other sites of relapse included (No. of cases/dia</a> <a title="EBMT Annual Meeting 2015 Absract Book page 49" href="http://viewer.zmags.com/publication/b0929dae?page=49"> Conclusion: In this study, we show that th</a> <a title="EBMT Annual Meeting 2015 Absract Book page 50" href="http://viewer.zmags.com/publication/b0929dae?page=50"> who had primary graft failure were successf</a> <a title="EBMT Annual Meeting 2015 Absract Book page 51" href="http://viewer.zmags.com/publication/b0929dae?page=51"> and myeloid leukemias, the omission of </a> <a title="EBMT Annual Meeting 2015 Absract Book page 52" href="http://viewer.zmags.com/publication/b0929dae?page=52"> Results: 279 patients (110 females and 169 </a> <a title="EBMT Annual Meeting 2015 Absract Book page 53" href="http://viewer.zmags.com/publication/b0929dae?page=53"> variable even in patients with an equal weight re</a> <a title="EBMT Annual Meeting 2015 Absract Book page 54" href="http://viewer.zmags.com/publication/b0929dae?page=54"> O074 Efficacy and Safety of Hematopoietic Stem Cel</a> <a title="EBMT Annual Meeting 2015 Absract Book page 55" href="http://viewer.zmags.com/publication/b0929dae?page=55"> O076 Parental Haploidentical HSCT with a Post-Inf</a> <a title="EBMT Annual Meeting 2015 Absract Book page 56" href="http://viewer.zmags.com/publication/b0929dae?page=56"> [O077] management. We pre</a> <a title="EBMT Annual Meeting 2015 Absract Book page 57" href="http://viewer.zmags.com/publication/b0929dae?page=57"> O079 ATG vs. Thiotepa in addition to BuCy for low</a> <a title="EBMT Annual Meeting 2015 Absract Book page 58" href="http://viewer.zmags.com/publication/b0929dae?page=58"> Oral session: Stem cell mobilization & regenerati</a> <a title="EBMT Annual Meeting 2015 Absract Book page 59" href="http://viewer.zmags.com/publication/b0929dae?page=59"> and ANGP-1 pre-mobilization levels may serve</a> <a title="EBMT Annual Meeting 2015 Absract Book page 60" href="http://viewer.zmags.com/publication/b0929dae?page=60"> setting in terms of collection efficiency and coll</a> <a title="EBMT Annual Meeting 2015 Absract Book page 61" href="http://viewer.zmags.com/publication/b0929dae?page=61"> O087 Acute GvHD after Alemtuzumab based condition</a> <a title="EBMT Annual Meeting 2015 Absract Book page 62" href="http://viewer.zmags.com/publication/b0929dae?page=62"> O089 In vivo expansion of host type regulatory T </a> <a title="EBMT Annual Meeting 2015 Absract Book page 63" href="http://viewer.zmags.com/publication/b0929dae?page=63"> Oral session: Solid tumors O091 Impact of resp</a> <a title="EBMT Annual Meeting 2015 Absract Book page 64" href="http://viewer.zmags.com/publication/b0929dae?page=64"> chemo-resistant, 6 MYCN amplification and 2 older </a> <a title="EBMT Annual Meeting 2015 Absract Book page 65" href="http://viewer.zmags.com/publication/b0929dae?page=65"> O094 Impact of prior paclitaxel-based chemotherap</a> <a title="EBMT Annual Meeting 2015 Absract Book page 66" href="http://viewer.zmags.com/publication/b0929dae?page=66"> the human epidermal growth factor receptor 2 (HER</a> <a title="EBMT Annual Meeting 2015 Absract Book page 67" href="http://viewer.zmags.com/publication/b0929dae?page=67"> autoHCT appear enhancing and both types of transp</a> <a title="EBMT Annual Meeting 2015 Absract Book page 68" href="http://viewer.zmags.com/publication/b0929dae?page=68"> group is conducting the ALL-2009 trial wher</a> <a title="EBMT Annual Meeting 2015 Absract Book page 69" href="http://viewer.zmags.com/publication/b0929dae?page=69"> terms of long-term survival between initiall</a> <a title="EBMT Annual Meeting 2015 Absract Book page 70" href="http://viewer.zmags.com/publication/b0929dae?page=70"> SLE patients (at 18, 36, and 80 months, respectiv</a> <a title="EBMT Annual Meeting 2015 Absract Book page 71" href="http://viewer.zmags.com/publication/b0929dae?page=71"> O104 Autologous haematopoietic stem cell transpla</a> <a title="EBMT Annual Meeting 2015 Absract Book page 72" href="http://viewer.zmags.com/publication/b0929dae?page=72"> Oral session: Stem cell source and graft composit</a> <a title="EBMT Annual Meeting 2015 Absract Book page 73" href="http://viewer.zmags.com/publication/b0929dae?page=73"> Conclusion: We found no impact of CD34 Þ and CD3 </a> <a title="EBMT Annual Meeting 2015 Absract Book page 74" href="http://viewer.zmags.com/publication/b0929dae?page=74"> expression of genes associated with innate immun</a> <a title="EBMT Annual Meeting 2015 Absract Book page 75" href="http://viewer.zmags.com/publication/b0929dae?page=75"> graft failure (3 of them showing third par</a> <a title="EBMT Annual Meeting 2015 Absract Book page 76" href="http://viewer.zmags.com/publication/b0929dae?page=76"> pts with HL at risk of relapse post</a> <a title="EBMT Annual Meeting 2015 Absract Book page 77" href="http://viewer.zmags.com/publication/b0929dae?page=77"> Univariate statistical analysis suggested limited</a> <a title="EBMT Annual Meeting 2015 Absract Book page 78" href="http://viewer.zmags.com/publication/b0929dae?page=78"> transplant group was significantly higher than tha</a> <a title="EBMT Annual Meeting 2015 Absract Book page 79" href="http://viewer.zmags.com/publication/b0929dae?page=79"> Results: Median age at the time of ASCT was 56 ye</a> <a title="EBMT Annual Meeting 2015 Absract Book page 80" href="http://viewer.zmags.com/publication/b0929dae?page=80"> O119 What is an acceptably low transplant related</a> <a title="EBMT Annual Meeting 2015 Absract Book page 81" href="http://viewer.zmags.com/publication/b0929dae?page=81"> O120 Decision-finding for allogeneic stem cell Tra</a> <a title="EBMT Annual Meeting 2015 Absract Book page 82" href="http://viewer.zmags.com/publication/b0929dae?page=82"> better control of the disease: this has occurred </a> <a title="EBMT Annual Meeting 2015 Absract Book page 83" href="http://viewer.zmags.com/publication/b0929dae?page=83"> therefore a reduced intensity conditioning approa</a> <a title="EBMT Annual Meeting 2015 Absract Book page 84" href="http://viewer.zmags.com/publication/b0929dae?page=84"> Endpoints were OS, aGVHD II-IV and III-IV, extens</a> <a title="EBMT Annual Meeting 2015 Absract Book page 85" href="http://viewer.zmags.com/publication/b0929dae?page=85"> without MOF) per modified Seattle criteria (</a> <a title="EBMT Annual Meeting 2015 Absract Book page 86" href="http://viewer.zmags.com/publication/b0929dae?page=86"> O129 Effectiveness of preventive parenteral nutri</a> <a title="EBMT Annual Meeting 2015 Absract Book page 87" href="http://viewer.zmags.com/publication/b0929dae?page=87"> Materials (or patients) and methods: In a </a> <a title="EBMT Annual Meeting 2015 Absract Book page 88" href="http://viewer.zmags.com/publication/b0929dae?page=88"> O133 HLA matching influences the risk of recurrent</a> <a title="EBMT Annual Meeting 2015 Absract Book page 89" href="http://viewer.zmags.com/publication/b0929dae?page=89"> O135 Selection of adenovirus and Epstein-Barr-vir</a> <a title="EBMT Annual Meeting 2015 Absract Book page 90" href="http://viewer.zmags.com/publication/b0929dae?page=90"> O137 Viral isolates with lamivudine resistance an</a> <a title="EBMT Annual Meeting 2015 Absract Book page 91" href="http://viewer.zmags.com/publication/b0929dae?page=91"> Conclusion: In this cohort of 149 T-cell replete </a> <a title="EBMT Annual Meeting 2015 Absract Book page 92" href="http://viewer.zmags.com/publication/b0929dae?page=92"> relapse who would benefit from further treatment i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 93" href="http://viewer.zmags.com/publication/b0929dae?page=93"> adverse risk cytogenetic (P ¼ 0.04). In patients </a> <a title="EBMT Annual Meeting 2015 Absract Book page 94" href="http://viewer.zmags.com/publication/b0929dae?page=94"> features allow minutely monitoring chimerism dyna</a> <a title="EBMT Annual Meeting 2015 Absract Book page 95" href="http://viewer.zmags.com/publication/b0929dae?page=95"> marrow samples with standard methods and in accor</a> <a title="EBMT Annual Meeting 2015 Absract Book page 96" href="http://viewer.zmags.com/publication/b0929dae?page=96"> O147 Immunosuppressive therapy versus alternative</a> <a title="EBMT Annual Meeting 2015 Absract Book page 97" href="http://viewer.zmags.com/publication/b0929dae?page=97"> O149 Graft depletion of TCRalpha/beta and CD19 in</a> <a title="EBMT Annual Meeting 2015 Absract Book page 98" href="http://viewer.zmags.com/publication/b0929dae?page=98"> TP:129 (34) vs 173 (36) cm/s, respectively; (Po0.</a> <a title="EBMT Annual Meeting 2015 Absract Book page 99" href="http://viewer.zmags.com/publication/b0929dae?page=99"> Oral session: Late complications & quality of lif</a> <a title="EBMT Annual Meeting 2015 Absract Book page 100" href="http://viewer.zmags.com/publication/b0929dae?page=100"> mmol/L), and ECOG status 40 (31.1 vs 20.2%). Pati</a> <a title="EBMT Annual Meeting 2015 Absract Book page 101" href="http://viewer.zmags.com/publication/b0929dae?page=101"> Conclusion: Our results may be summarized as foll</a> <a title="EBMT Annual Meeting 2015 Absract Book page 102" href="http://viewer.zmags.com/publication/b0929dae?page=102"> standards, a third of centres had held no LE educ</a> <a title="EBMT Annual Meeting 2015 Absract Book page 103" href="http://viewer.zmags.com/publication/b0929dae?page=103"> in vivo and to unravel the requirements for their</a> <a title="EBMT Annual Meeting 2015 Absract Book page 104" href="http://viewer.zmags.com/publication/b0929dae?page=104"> O162 Human T Regulatory Cells Expressing a Chimer</a> <a title="EBMT Annual Meeting 2015 Absract Book page 105" href="http://viewer.zmags.com/publication/b0929dae?page=105"> O164 Adoptive T-cell immunotherapy with hexon-spe</a> <a title="EBMT Annual Meeting 2015 Absract Book page 106" href="http://viewer.zmags.com/publication/b0929dae?page=106"> O165 Use of zoledronic acid after TcRab/CD19-depl</a> <a title="EBMT Annual Meeting 2015 Absract Book page 107" href="http://viewer.zmags.com/publication/b0929dae?page=107"> WORKING PARTIES Acute Leukemia WP001 Gen</a> <a title="EBMT Annual Meeting 2015 Absract Book page 108" href="http://viewer.zmags.com/publication/b0929dae?page=108"> r50 years old had better overall survival </a> <a title="EBMT Annual Meeting 2015 Absract Book page 109" href="http://viewer.zmags.com/publication/b0929dae?page=109"> of patients with AA and a lymphoid neoplasm accor</a> <a title="EBMT Annual Meeting 2015 Absract Book page 110" href="http://viewer.zmags.com/publication/b0929dae?page=110"> WP009 Outcome of bone marrow transplantation in d</a> <a title="EBMT Annual Meeting 2015 Absract Book page 111" href="http://viewer.zmags.com/publication/b0929dae?page=111"> From beginning of 2011 OKT3 was taken from the ma</a> <a title="EBMT Annual Meeting 2015 Absract Book page 112" href="http://viewer.zmags.com/publication/b0929dae?page=112"> donor, stem cell source, use of T cell depletion,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 113" href="http://viewer.zmags.com/publication/b0929dae?page=113"> This survey shows a distinct heterogeneity both i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 114" href="http://viewer.zmags.com/publication/b0929dae?page=114"> at the University Hospitals of Leuven where the t</a> <a title="EBMT Annual Meeting 2015 Absract Book page 115" href="http://viewer.zmags.com/publication/b0929dae?page=115"> WP021 Hematopoietic stem cell transplantation bet</a> <a title="EBMT Annual Meeting 2015 Absract Book page 116" href="http://viewer.zmags.com/publication/b0929dae?page=116"> Conclusion: Outcome in HSCT for SCID has s</a> <a title="EBMT Annual Meeting 2015 Absract Book page 117" href="http://viewer.zmags.com/publication/b0929dae?page=117"> [WP023] </a> <a title="EBMT Annual Meeting 2015 Absract Book page 118" href="http://viewer.zmags.com/publication/b0929dae?page=118"> described. Disease status at HCT was CR in 11%, P</a> <a title="EBMT Annual Meeting 2015 Absract Book page 119" href="http://viewer.zmags.com/publication/b0929dae?page=119"> have considerably improved the survival of multip</a> <a title="EBMT Annual Meeting 2015 Absract Book page 120" href="http://viewer.zmags.com/publication/b0929dae?page=120"> the higher risk MDS. Actually, some lower risk pa</a> <a title="EBMT Annual Meeting 2015 Absract Book page 121" href="http://viewer.zmags.com/publication/b0929dae?page=121"> depletion of the graft. However, patients treated</a> <a title="EBMT Annual Meeting 2015 Absract Book page 122" href="http://viewer.zmags.com/publication/b0929dae?page=122"> with the objective of exploring innovative </a> <a title="EBMT Annual Meeting 2015 Absract Book page 123" href="http://viewer.zmags.com/publication/b0929dae?page=123"> cellular therapy development. Ref McG</a> <a title="EBMT Annual Meeting 2015 Absract Book page 124" href="http://viewer.zmags.com/publication/b0929dae?page=124"> WP038 Updated recommandations for cardiopulmonary</a> <a title="EBMT Annual Meeting 2015 Absract Book page 125" href="http://viewer.zmags.com/publication/b0929dae?page=125"> This is the reason why the EBMT-STWP is currently</a> <a title="EBMT Annual Meeting 2015 Absract Book page 126" href="http://viewer.zmags.com/publication/b0929dae?page=126"> disseminated tumor cells (DTCs) and constitute a </a> <a title="EBMT Annual Meeting 2015 Absract Book page 127" href="http://viewer.zmags.com/publication/b0929dae?page=127"> PHYSICIANS POSTER SESSIONS Poster Session 1</a> <a title="EBMT Annual Meeting 2015 Absract Book page 128" href="http://viewer.zmags.com/publication/b0929dae?page=128"> Results: The median cost in group 1 (15 patients)</a> <a title="EBMT Annual Meeting 2015 Absract Book page 129" href="http://viewer.zmags.com/publication/b0929dae?page=129"> approach for clinical scale iNKT selection and ex</a> <a title="EBMT Annual Meeting 2015 Absract Book page 130" href="http://viewer.zmags.com/publication/b0929dae?page=130"> [P007] debris depletion, precise determ</a> <a title="EBMT Annual Meeting 2015 Absract Book page 131" href="http://viewer.zmags.com/publication/b0929dae?page=131"> [P009] Platelet l</a> <a title="EBMT Annual Meeting 2015 Absract Book page 132" href="http://viewer.zmags.com/publication/b0929dae?page=132"> Results: The majority of gd T-cells in the booste</a> <a title="EBMT Annual Meeting 2015 Absract Book page 133" href="http://viewer.zmags.com/publication/b0929dae?page=133"> [P012] (MM: 2, CLL: 1, HL: </a> <a title="EBMT Annual Meeting 2015 Absract Book page 134" href="http://viewer.zmags.com/publication/b0929dae?page=134"> Materials (or patients) and methods: 25 millilite</a> <a title="EBMT Annual Meeting 2015 Absract Book page 135" href="http://viewer.zmags.com/publication/b0929dae?page=135"> and MDS 7-. In case of other 2 patients with MDS </a> <a title="EBMT Annual Meeting 2015 Absract Book page 136" href="http://viewer.zmags.com/publication/b0929dae?page=136"> risk. Despite many centres adopting this approach</a> <a title="EBMT Annual Meeting 2015 Absract Book page 137" href="http://viewer.zmags.com/publication/b0929dae?page=137"> partial remission. Renal activity evaluated </a> <a title="EBMT Annual Meeting 2015 Absract Book page 138" href="http://viewer.zmags.com/publication/b0929dae?page=138"> Conclusion: Haploidentical T-cell repleted </a> <a title="EBMT Annual Meeting 2015 Absract Book page 139" href="http://viewer.zmags.com/publication/b0929dae?page=139"> patients received G-CSF after transplant, other i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 140" href="http://viewer.zmags.com/publication/b0929dae?page=140"> P026 Successful bone marrow processing for transp</a> <a title="EBMT Annual Meeting 2015 Absract Book page 141" href="http://viewer.zmags.com/publication/b0929dae?page=141"> [P028] cell transplantat</a> <a title="EBMT Annual Meeting 2015 Absract Book page 142" href="http://viewer.zmags.com/publication/b0929dae?page=142"> P030 Comparative study of two techniques for rout</a> <a title="EBMT Annual Meeting 2015 Absract Book page 143" href="http://viewer.zmags.com/publication/b0929dae?page=143"> on day 312. With a median follow-up of 20 months </a> <a title="EBMT Annual Meeting 2015 Absract Book page 144" href="http://viewer.zmags.com/publication/b0929dae?page=144"> P034 Clinical relevance of anti-HLA Antibodies an</a> <a title="EBMT Annual Meeting 2015 Absract Book page 145" href="http://viewer.zmags.com/publication/b0929dae?page=145"> matched related (21%) or HLA-matched (56%) or mis</a> <a title="EBMT Annual Meeting 2015 Absract Book page 146" href="http://viewer.zmags.com/publication/b0929dae?page=146"> [P037] </a> <a title="EBMT Annual Meeting 2015 Absract Book page 147" href="http://viewer.zmags.com/publication/b0929dae?page=147"> [P038] Two patien</a> <a title="EBMT Annual Meeting 2015 Absract Book page 148" href="http://viewer.zmags.com/publication/b0929dae?page=148"> levels of IgG and IgA with high or normal</a> <a title="EBMT Annual Meeting 2015 Absract Book page 149" href="http://viewer.zmags.com/publication/b0929dae?page=149"> antibiotics lengthend hospitalization. The an</a> <a title="EBMT Annual Meeting 2015 Absract Book page 150" href="http://viewer.zmags.com/publication/b0929dae?page=150"> (SCT) in patients with multiple myeloma (MM) to a</a> <a title="EBMT Annual Meeting 2015 Absract Book page 151" href="http://viewer.zmags.com/publication/b0929dae?page=151"> undergoing alloSCT in our institution</a> <a title="EBMT Annual Meeting 2015 Absract Book page 152" href="http://viewer.zmags.com/publication/b0929dae?page=152"> (AA) substitution bA-T87Q from the g and d</a> <a title="EBMT Annual Meeting 2015 Absract Book page 153" href="http://viewer.zmags.com/publication/b0929dae?page=153"> P050 A clinically feasible protocol of TCR gene e</a> <a title="EBMT Annual Meeting 2015 Absract Book page 154" href="http://viewer.zmags.com/publication/b0929dae?page=154"> cultured cells of BM-origin were negative for hem</a> <a title="EBMT Annual Meeting 2015 Absract Book page 155" href="http://viewer.zmags.com/publication/b0929dae?page=155"> P054 Chemical inducers of Endoplasmic Reticulum (</a> <a title="EBMT Annual Meeting 2015 Absract Book page 156" href="http://viewer.zmags.com/publication/b0929dae?page=156"> T was examined by flow cytometry and the level of </a> <a title="EBMT Annual Meeting 2015 Absract Book page 157" href="http://viewer.zmags.com/publication/b0929dae?page=157"> suppressing proliferation of peripheral blood</a> <a title="EBMT Annual Meeting 2015 Absract Book page 158" href="http://viewer.zmags.com/publication/b0929dae?page=158"> produced in its inactive form. Interestingly, the</a> <a title="EBMT Annual Meeting 2015 Absract Book page 159" href="http://viewer.zmags.com/publication/b0929dae?page=159"> proportion of HSPC after co-culture for 7days, an</a> <a title="EBMT Annual Meeting 2015 Absract Book page 160" href="http://viewer.zmags.com/publication/b0929dae?page=160"> Results: Donors' characteristics are shown in tab</a> <a title="EBMT Annual Meeting 2015 Absract Book page 161" href="http://viewer.zmags.com/publication/b0929dae?page=161"> multicopy locus on the Y chromosome (DYS-1, detec</a> <a title="EBMT Annual Meeting 2015 Absract Book page 162" href="http://viewer.zmags.com/publication/b0929dae?page=162"> Diagnosis Conditioning GVHD Neut </a> <a title="EBMT Annual Meeting 2015 Absract Book page 163" href="http://viewer.zmags.com/publication/b0929dae?page=163"> P072 Allogeneic versus Autologous Hematopoietic S</a> <a title="EBMT Annual Meeting 2015 Absract Book page 164" href="http://viewer.zmags.com/publication/b0929dae?page=164"> transplants were excluded. Based on practice</a> <a title="EBMT Annual Meeting 2015 Absract Book page 165" href="http://viewer.zmags.com/publication/b0929dae?page=165"> grouped in respect to amino acid 80 into C1 (aspa</a> <a title="EBMT Annual Meeting 2015 Absract Book page 166" href="http://viewer.zmags.com/publication/b0929dae?page=166"> (CI) of 96.4% without any difference between the </a> <a title="EBMT Annual Meeting 2015 Absract Book page 167" href="http://viewer.zmags.com/publication/b0929dae?page=167"> P080 Hematopoietic stem cell donors – analysis of</a> <a title="EBMT Annual Meeting 2015 Absract Book page 168" href="http://viewer.zmags.com/publication/b0929dae?page=168"> HLA match between donor and recipient. </a> <a title="EBMT Annual Meeting 2015 Absract Book page 169" href="http://viewer.zmags.com/publication/b0929dae?page=169"> collection, a medical visit and a CBC after 30 da</a> <a title="EBMT Annual Meeting 2015 Absract Book page 170" href="http://viewer.zmags.com/publication/b0929dae?page=170"> bone marrow failure. Allogeneic hematopoietic</a> <a title="EBMT Annual Meeting 2015 Absract Book page 171" href="http://viewer.zmags.com/publication/b0929dae?page=171"> Graft-versus-host disease – clinical I P088 Pl</a> <a title="EBMT Annual Meeting 2015 Absract Book page 172" href="http://viewer.zmags.com/publication/b0929dae?page=172"> to histologically proven GvHD with negative micro</a> <a title="EBMT Annual Meeting 2015 Absract Book page 173" href="http://viewer.zmags.com/publication/b0929dae?page=173"> therapies were prescribed for the majority of pat</a> <a title="EBMT Annual Meeting 2015 Absract Book page 174" href="http://viewer.zmags.com/publication/b0929dae?page=174"> population and the low incidence of overall and s</a> <a title="EBMT Annual Meeting 2015 Absract Book page 175" href="http://viewer.zmags.com/publication/b0929dae?page=175"> survival (74% vs 43.2%, HR ¼ 0.370, 95%</a> <a title="EBMT Annual Meeting 2015 Absract Book page 176" href="http://viewer.zmags.com/publication/b0929dae?page=176"> Disclosure of Interest: C. Human: None declared, </a> <a title="EBMT Annual Meeting 2015 Absract Book page 177" href="http://viewer.zmags.com/publication/b0929dae?page=177"> P100 Parameters of Protein Metabolism and Thyroid</a> <a title="EBMT Annual Meeting 2015 Absract Book page 178" href="http://viewer.zmags.com/publication/b0929dae?page=178"> Additionally, Rifaximin seemed to exert a protect</a> <a title="EBMT Annual Meeting 2015 Absract Book page 179" href="http://viewer.zmags.com/publication/b0929dae?page=179"> Results: The median time to onset of HC after all</a> <a title="EBMT Annual Meeting 2015 Absract Book page 180" href="http://viewer.zmags.com/publication/b0929dae?page=180"> classic cGVHD. Ten (50%) patients had moderate an</a> <a title="EBMT Annual Meeting 2015 Absract Book page 181" href="http://viewer.zmags.com/publication/b0929dae?page=181"> [P107] relation</a> <a title="EBMT Annual Meeting 2015 Absract Book page 182" href="http://viewer.zmags.com/publication/b0929dae?page=182"> [P108] related donors (</a> <a title="EBMT Annual Meeting 2015 Absract Book page 183" href="http://viewer.zmags.com/publication/b0929dae?page=183"> GvHD prior to day 100 is not recognized by </a> <a title="EBMT Annual Meeting 2015 Absract Book page 184" href="http://viewer.zmags.com/publication/b0929dae?page=184"> Results: While 43 (38.7%) patients did not develo</a> <a title="EBMT Annual Meeting 2015 Absract Book page 185" href="http://viewer.zmags.com/publication/b0929dae?page=185"> Results: Between 2005 and 2014, 29 patients</a> <a title="EBMT Annual Meeting 2015 Absract Book page 186" href="http://viewer.zmags.com/publication/b0929dae?page=186"> of 8 patients with eye involvement, 3 out of 5 wi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 187" href="http://viewer.zmags.com/publication/b0929dae?page=187"> [P117] Conclusion: This is the</a> <a title="EBMT Annual Meeting 2015 Absract Book page 188" href="http://viewer.zmags.com/publication/b0929dae?page=188"> P119 GVHD-Associated Early Impairment of Marrow F</a> <a title="EBMT Annual Meeting 2015 Absract Book page 189" href="http://viewer.zmags.com/publication/b0929dae?page=189"> GVHD prophylaxis consisted of cyclosporine or tac</a> <a title="EBMT Annual Meeting 2015 Absract Book page 190" href="http://viewer.zmags.com/publication/b0929dae?page=190"> multipotent mesenchymal stromal cells (MSC) was d</a> <a title="EBMT Annual Meeting 2015 Absract Book page 191" href="http://viewer.zmags.com/publication/b0929dae?page=191"> P124 Efficacy of Infliximab for the Treatment of Ac</a> <a title="EBMT Annual Meeting 2015 Absract Book page 192" href="http://viewer.zmags.com/publication/b0929dae?page=192"> Materials (or patients) and methods: Patients wer</a> <a title="EBMT Annual Meeting 2015 Absract Book page 193" href="http://viewer.zmags.com/publication/b0929dae?page=193"> P128 The activating NKG2C receptor is significantl</a> <a title="EBMT Annual Meeting 2015 Absract Book page 194" href="http://viewer.zmags.com/publication/b0929dae?page=194"> chronic graft versus host disease (cGVHD). Althou</a> <a title="EBMT Annual Meeting 2015 Absract Book page 195" href="http://viewer.zmags.com/publication/b0929dae?page=195"> Table 2. Main results in 2 groups FK Þ BM vs C</a> <a title="EBMT Annual Meeting 2015 Absract Book page 196" href="http://viewer.zmags.com/publication/b0929dae?page=196"> respiratory tract infections occurred in 27.5% of</a> <a title="EBMT Annual Meeting 2015 Absract Book page 197" href="http://viewer.zmags.com/publication/b0929dae?page=197"> colonized or previously infected pts is therefore</a> <a title="EBMT Annual Meeting 2015 Absract Book page 198" href="http://viewer.zmags.com/publication/b0929dae?page=198"> after novel type of selective T-depletion -</a> <a title="EBMT Annual Meeting 2015 Absract Book page 199" href="http://viewer.zmags.com/publication/b0929dae?page=199"> anemias (n ¼ 12), neuroblastoma (n ¼ 5), inherite</a> <a title="EBMT Annual Meeting 2015 Absract Book page 200" href="http://viewer.zmags.com/publication/b0929dae?page=200"> frequent pathogen detected, with an active </a> <a title="EBMT Annual Meeting 2015 Absract Book page 201" href="http://viewer.zmags.com/publication/b0929dae?page=201"> HC was classified as grade 1 in 1 patient (5%), gr</a> <a title="EBMT Annual Meeting 2015 Absract Book page 202" href="http://viewer.zmags.com/publication/b0929dae?page=202"> clinicians to early diagnosis, especially in</a> <a title="EBMT Annual Meeting 2015 Absract Book page 203" href="http://viewer.zmags.com/publication/b0929dae?page=203"> transplantation (HSCT) with a high impact o</a> <a title="EBMT Annual Meeting 2015 Absract Book page 204" href="http://viewer.zmags.com/publication/b0929dae?page=204"> 14% had hospital acquired E. coli bacteraemia. Si</a> <a title="EBMT Annual Meeting 2015 Absract Book page 205" href="http://viewer.zmags.com/publication/b0929dae?page=205"> 1 cord blood transplant, 14 sibling allogra</a> <a title="EBMT Annual Meeting 2015 Absract Book page 206" href="http://viewer.zmags.com/publication/b0929dae?page=206"> stool and urine were collected. Microbiological i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 207" href="http://viewer.zmags.com/publication/b0929dae?page=207"> and neutrophile engraftment was registered. </a> <a title="EBMT Annual Meeting 2015 Absract Book page 208" href="http://viewer.zmags.com/publication/b0929dae?page=208"> (RIC vs MAC) or the presence of acute GvHD or ste</a> <a title="EBMT Annual Meeting 2015 Absract Book page 209" href="http://viewer.zmags.com/publication/b0929dae?page=209"> cells was 1- to 33-fold while IE1-specific T cells</a> <a title="EBMT Annual Meeting 2015 Absract Book page 210" href="http://viewer.zmags.com/publication/b0929dae?page=210"> Reactivation of either HHV6 or EBV constituted th</a> <a title="EBMT Annual Meeting 2015 Absract Book page 211" href="http://viewer.zmags.com/publication/b0929dae?page=211"> it has activity against all major Can</a> <a title="EBMT Annual Meeting 2015 Absract Book page 212" href="http://viewer.zmags.com/publication/b0929dae?page=212"> detected positive in stool sample with immu</a> <a title="EBMT Annual Meeting 2015 Absract Book page 213" href="http://viewer.zmags.com/publication/b0929dae?page=213"> peripheral blood SCT, 6 (3.8%) to bone marrow SCT</a> <a title="EBMT Annual Meeting 2015 Absract Book page 214" href="http://viewer.zmags.com/publication/b0929dae?page=214"> However, vaccines given at 2 years were considera</a> <a title="EBMT Annual Meeting 2015 Absract Book page 215" href="http://viewer.zmags.com/publication/b0929dae?page=215"> was higher in HSCT patients for bacterial (33.9%</a> <a title="EBMT Annual Meeting 2015 Absract Book page 216" href="http://viewer.zmags.com/publication/b0929dae?page=216"> conditioning (MAC) was provided to 54 patie</a> <a title="EBMT Annual Meeting 2015 Absract Book page 217" href="http://viewer.zmags.com/publication/b0929dae?page=217"> P177 Chemotherapy-induced nausea and vomiting in </a> <a title="EBMT Annual Meeting 2015 Absract Book page 218" href="http://viewer.zmags.com/publication/b0929dae?page=218"> to assess the risk factors for developing early, </a> <a title="EBMT Annual Meeting 2015 Absract Book page 219" href="http://viewer.zmags.com/publication/b0929dae?page=219"> Results: With a median follow-up of 55 mon</a> <a title="EBMT Annual Meeting 2015 Absract Book page 220" href="http://viewer.zmags.com/publication/b0929dae?page=220"> evaluated by X2 test, continuous variab</a> <a title="EBMT Annual Meeting 2015 Absract Book page 221" href="http://viewer.zmags.com/publication/b0929dae?page=221"> P186 Central Venous Catheter Related Complication</a> <a title="EBMT Annual Meeting 2015 Absract Book page 222" href="http://viewer.zmags.com/publication/b0929dae?page=222"> P188 Restrospective comparative analysis of clini</a> <a title="EBMT Annual Meeting 2015 Absract Book page 223" href="http://viewer.zmags.com/publication/b0929dae?page=223"> P190 Peripherally Inserted Central Catheter (PICC</a> <a title="EBMT Annual Meeting 2015 Absract Book page 224" href="http://viewer.zmags.com/publication/b0929dae?page=224"> P192 Analysis of early life-threatening complicat</a> <a title="EBMT Annual Meeting 2015 Absract Book page 225" href="http://viewer.zmags.com/publication/b0929dae?page=225"> 2. Colvin GA, Berz D, Ramanathan M, Winer ES, Fas</a> <a title="EBMT Annual Meeting 2015 Absract Book page 226" href="http://viewer.zmags.com/publication/b0929dae?page=226"> P196 Safety and feasibility of romiplostim treatm</a> <a title="EBMT Annual Meeting 2015 Absract Book page 227" href="http://viewer.zmags.com/publication/b0929dae?page=227"> even in patients on immune suppression. We carrie</a> <a title="EBMT Annual Meeting 2015 Absract Book page 228" href="http://viewer.zmags.com/publication/b0929dae?page=228"> patients with benign and malign hematological dis</a> <a title="EBMT Annual Meeting 2015 Absract Book page 229" href="http://viewer.zmags.com/publication/b0929dae?page=229"> P202 Prospective, randomized trial of physical fu</a> <a title="EBMT Annual Meeting 2015 Absract Book page 230" href="http://viewer.zmags.com/publication/b0929dae?page=230"> Here, we report the outcome of a cohort of paedia</a> <a title="EBMT Annual Meeting 2015 Absract Book page 231" href="http://viewer.zmags.com/publication/b0929dae?page=231"> Conditioning regimen I P207 Therapeutic drug m</a> <a title="EBMT Annual Meeting 2015 Absract Book page 232" href="http://viewer.zmags.com/publication/b0929dae?page=232"> included in a prospective multicenter trial </a> <a title="EBMT Annual Meeting 2015 Absract Book page 233" href="http://viewer.zmags.com/publication/b0929dae?page=233"> P211 Reduced risk of oral mucositis among autoHSC</a> <a title="EBMT Annual Meeting 2015 Absract Book page 234" href="http://viewer.zmags.com/publication/b0929dae?page=234"> P213 Research of Iron chelator treatment in allog</a> <a title="EBMT Annual Meeting 2015 Absract Book page 235" href="http://viewer.zmags.com/publication/b0929dae?page=235"> Germany, we collected registry data of 1844 patie</a> <a title="EBMT Annual Meeting 2015 Absract Book page 236" href="http://viewer.zmags.com/publication/b0929dae?page=236"> syndrome (SOS) (P ¼ 0.001). A statistically signi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 237" href="http://viewer.zmags.com/publication/b0929dae?page=237"> 5.1 mg/kg/day (related to adjusted body weight), </a> <a title="EBMT Annual Meeting 2015 Absract Book page 238" href="http://viewer.zmags.com/publication/b0929dae?page=238"> P221 Comparison of two conditioning regimen for a</a> <a title="EBMT Annual Meeting 2015 Absract Book page 239" href="http://viewer.zmags.com/publication/b0929dae?page=239"> Conclusion: In conclusion, based on these result </a> <a title="EBMT Annual Meeting 2015 Absract Book page 240" href="http://viewer.zmags.com/publication/b0929dae?page=240"> sufficient immunosuppressive activity for engraftm</a> <a title="EBMT Annual Meeting 2015 Absract Book page 241" href="http://viewer.zmags.com/publication/b0929dae?page=241"> P226 Comparable outcomes of hematopoietic stem ce</a> <a title="EBMT Annual Meeting 2015 Absract Book page 242" href="http://viewer.zmags.com/publication/b0929dae?page=242"> biomarkers to predict busulfan pharmacokinetics u</a> <a title="EBMT Annual Meeting 2015 Absract Book page 243" href="http://viewer.zmags.com/publication/b0929dae?page=243"> Minimal residual disease, tolerance, chimerism an</a> <a title="EBMT Annual Meeting 2015 Absract Book page 244" href="http://viewer.zmags.com/publication/b0929dae?page=244"> mycophenolate for Haploid and CsA/methotrexate fo</a> <a title="EBMT Annual Meeting 2015 Absract Book page 245" href="http://viewer.zmags.com/publication/b0929dae?page=245"> P235 Donor KIR A haplotype is associated with an </a> <a title="EBMT Annual Meeting 2015 Absract Book page 246" href="http://viewer.zmags.com/publication/b0929dae?page=246"> P237 Immunogenetic Cross-Talk in Patients Transpl</a> <a title="EBMT Annual Meeting 2015 Absract Book page 247" href="http://viewer.zmags.com/publication/b0929dae?page=247"> HSCT and post transplant immunotherapy need to be</a> <a title="EBMT Annual Meeting 2015 Absract Book page 248" href="http://viewer.zmags.com/publication/b0929dae?page=248"> automate microchimerism analysis workflow usin</a> <a title="EBMT Annual Meeting 2015 Absract Book page 249" href="http://viewer.zmags.com/publication/b0929dae?page=249"> Results: With a median follow-up of 61 months, we</a> <a title="EBMT Annual Meeting 2015 Absract Book page 250" href="http://viewer.zmags.com/publication/b0929dae?page=250"> significant difference by 2-3 months. By 1 year fo</a> <a title="EBMT Annual Meeting 2015 Absract Book page 251" href="http://viewer.zmags.com/publication/b0929dae?page=251"> Conclusion: Monitoring of donor chimerism after a</a> <a title="EBMT Annual Meeting 2015 Absract Book page 252" href="http://viewer.zmags.com/publication/b0929dae?page=252"> study was to evaluate the efficacy of monitoring o</a> <a title="EBMT Annual Meeting 2015 Absract Book page 253" href="http://viewer.zmags.com/publication/b0929dae?page=253"> even the cytochrome b588 light chain compon</a> <a title="EBMT Annual Meeting 2015 Absract Book page 254" href="http://viewer.zmags.com/publication/b0929dae?page=254"> from MSD alive 12-138 (median 86) mon</a> <a title="EBMT Annual Meeting 2015 Absract Book page 255" href="http://viewer.zmags.com/publication/b0929dae?page=255"> species). At the time peritoneal drains were remo</a> <a title="EBMT Annual Meeting 2015 Absract Book page 256" href="http://viewer.zmags.com/publication/b0929dae?page=256"> Table 1. Transplant charactersitics and result</a> <a title="EBMT Annual Meeting 2015 Absract Book page 257" href="http://viewer.zmags.com/publication/b0929dae?page=257"> Table 1. Characteristics of patients and resul</a> <a title="EBMT Annual Meeting 2015 Absract Book page 258" href="http://viewer.zmags.com/publication/b0929dae?page=258"> patients was 7 years and 8 months (from 4 months </a> <a title="EBMT Annual Meeting 2015 Absract Book page 259" href="http://viewer.zmags.com/publication/b0929dae?page=259"> Results: UPN Disgnosis Virus ifection </a> <a title="EBMT Annual Meeting 2015 Absract Book page 260" href="http://viewer.zmags.com/publication/b0929dae?page=260"> (Mel)). Unfortunately, impaired reproductive </a> <a title="EBMT Annual Meeting 2015 Absract Book page 261" href="http://viewer.zmags.com/publication/b0929dae?page=261"> and December 2013. We defined IFI cases based on c</a> <a title="EBMT Annual Meeting 2015 Absract Book page 262" href="http://viewer.zmags.com/publication/b0929dae?page=262"> anemia, 19 with acquired SAA, 1 with CDA and 1 wi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 263" href="http://viewer.zmags.com/publication/b0929dae?page=263"> leukemia cells, as assessed by the degranul</a> <a title="EBMT Annual Meeting 2015 Absract Book page 264" href="http://viewer.zmags.com/publication/b0929dae?page=264"> rates. This study needs to be confirmed in larger,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 265" href="http://viewer.zmags.com/publication/b0929dae?page=265"> once weekly during immunosuppression. Positive ev</a> <a title="EBMT Annual Meeting 2015 Absract Book page 266" href="http://viewer.zmags.com/publication/b0929dae?page=266"> Hematopoietic Stem Cell Transplantation analysed </a> <a title="EBMT Annual Meeting 2015 Absract Book page 267" href="http://viewer.zmags.com/publication/b0929dae?page=267"> undergoing Allo-SCT in our institution from </a> <a title="EBMT Annual Meeting 2015 Absract Book page 268" href="http://viewer.zmags.com/publication/b0929dae?page=268"> had an average of AUC in the therapeutic window a</a> <a title="EBMT Annual Meeting 2015 Absract Book page 269" href="http://viewer.zmags.com/publication/b0929dae?page=269"> Materials (or patients) and methods: 1. new</a> <a title="EBMT Annual Meeting 2015 Absract Book page 270" href="http://viewer.zmags.com/publication/b0929dae?page=270"> of 54 (19.5-71) years, with normal diploid </a> <a title="EBMT Annual Meeting 2015 Absract Book page 271" href="http://viewer.zmags.com/publication/b0929dae?page=271"> of sorafenib. Remarkably, all patients </a> <a title="EBMT Annual Meeting 2015 Absract Book page 272" href="http://viewer.zmags.com/publication/b0929dae?page=272"> overall survival (OS) and disease free survival (</a> <a title="EBMT Annual Meeting 2015 Absract Book page 273" href="http://viewer.zmags.com/publication/b0929dae?page=273"> (16,9%) post induction (median 21; range:0,6-134.</a> <a title="EBMT Annual Meeting 2015 Absract Book page 274" href="http://viewer.zmags.com/publication/b0929dae?page=274"> [P288] </a> <a title="EBMT Annual Meeting 2015 Absract Book page 275" href="http://viewer.zmags.com/publication/b0929dae?page=275"> P290 BID, BAK AND BCL-XL expression in childhood</a> <a title="EBMT Annual Meeting 2015 Absract Book page 276" href="http://viewer.zmags.com/publication/b0929dae?page=276"> P292 Determination of copy number variation (CNV)</a> <a title="EBMT Annual Meeting 2015 Absract Book page 277" href="http://viewer.zmags.com/publication/b0929dae?page=277"> Conditioning regimen was myeloablative in 22</a> <a title="EBMT Annual Meeting 2015 Absract Book page 278" href="http://viewer.zmags.com/publication/b0929dae?page=278"> (ALL), the benefit of DSI was not obvious (1-year </a> <a title="EBMT Annual Meeting 2015 Absract Book page 279" href="http://viewer.zmags.com/publication/b0929dae?page=279"> There was no significant difference in survival ac</a> <a title="EBMT Annual Meeting 2015 Absract Book page 280" href="http://viewer.zmags.com/publication/b0929dae?page=280"> P300 Myeloablative Haploidentical Stem Cell Trans</a> <a title="EBMT Annual Meeting 2015 Absract Book page 281" href="http://viewer.zmags.com/publication/b0929dae?page=281"> P302 TCRab Þ /CD19 Þ -depletion in hematopoietic </a> <a title="EBMT Annual Meeting 2015 Absract Book page 282" href="http://viewer.zmags.com/publication/b0929dae?page=282"> impact on Overall Survival (OS) & Event-Free Surv</a> <a title="EBMT Annual Meeting 2015 Absract Book page 283" href="http://viewer.zmags.com/publication/b0929dae?page=283"> Patients surviving in the 3 periods were as follo</a> <a title="EBMT Annual Meeting 2015 Absract Book page 284" href="http://viewer.zmags.com/publication/b0929dae?page=284"> Further optimization of conditioning regimens can</a> <a title="EBMT Annual Meeting 2015 Absract Book page 285" href="http://viewer.zmags.com/publication/b0929dae?page=285"> Medical Park Samsun Hospital, Samsun, 14Pediatric</a> <a title="EBMT Annual Meeting 2015 Absract Book page 286" href="http://viewer.zmags.com/publication/b0929dae?page=286"> 77), respectively, without statistically sign</a> <a title="EBMT Annual Meeting 2015 Absract Book page 287" href="http://viewer.zmags.com/publication/b0929dae?page=287"> Lymphoma P314 Hematopoietic stem cell transpla</a> <a title="EBMT Annual Meeting 2015 Absract Book page 288" href="http://viewer.zmags.com/publication/b0929dae?page=288"> P316 Application of LYSA risk factors in patients</a> <a title="EBMT Annual Meeting 2015 Absract Book page 289" href="http://viewer.zmags.com/publication/b0929dae?page=289"> Materials (or patients) and methods: To inv</a> <a title="EBMT Annual Meeting 2015 Absract Book page 290" href="http://viewer.zmags.com/publication/b0929dae?page=290"> [P320] </a> <a title="EBMT Annual Meeting 2015 Absract Book page 291" href="http://viewer.zmags.com/publication/b0929dae?page=291"> Materials (or patients) and methods: In our</a> <a title="EBMT Annual Meeting 2015 Absract Book page 292" href="http://viewer.zmags.com/publication/b0929dae?page=292"> [P323] pentostatin/TBI20</a> <a title="EBMT Annual Meeting 2015 Absract Book page 293" href="http://viewer.zmags.com/publication/b0929dae?page=293"> P325 Analysis of clinical outcomes and prognostic</a> <a title="EBMT Annual Meeting 2015 Absract Book page 294" href="http://viewer.zmags.com/publication/b0929dae?page=294"> Centers (Firenze, Pisa, Siena) were eligible. Bas</a> <a title="EBMT Annual Meeting 2015 Absract Book page 295" href="http://viewer.zmags.com/publication/b0929dae?page=295"> blood at one month was associated with mal</a> <a title="EBMT Annual Meeting 2015 Absract Book page 296" href="http://viewer.zmags.com/publication/b0929dae?page=296"> P331 Simultaneous inhibition of CXCR4 and VLA-4 e</a> <a title="EBMT Annual Meeting 2015 Absract Book page 297" href="http://viewer.zmags.com/publication/b0929dae?page=297"> (ERK1/2, AKT, NF-kB). The reduction in phosphoryl</a> <a title="EBMT Annual Meeting 2015 Absract Book page 298" href="http://viewer.zmags.com/publication/b0929dae?page=298"> G. McQuaker Conflict with: Supported by an unrestr</a> <a title="EBMT Annual Meeting 2015 Absract Book page 299" href="http://viewer.zmags.com/publication/b0929dae?page=299"> consisting of a conclusive myeloablative chemothe</a> <a title="EBMT Annual Meeting 2015 Absract Book page 300" href="http://viewer.zmags.com/publication/b0929dae?page=300"> Results: Data of the 164 lymphoma patients </a> <a title="EBMT Annual Meeting 2015 Absract Book page 301" href="http://viewer.zmags.com/publication/b0929dae?page=301"> [P338] Conclusion: </a> <a title="EBMT Annual Meeting 2015 Absract Book page 302" href="http://viewer.zmags.com/publication/b0929dae?page=302"> [P339] P340 High dose </a> <a title="EBMT Annual Meeting 2015 Absract Book page 303" href="http://viewer.zmags.com/publication/b0929dae?page=303"> patients) as compared to no event was observed in</a> <a title="EBMT Annual Meeting 2015 Absract Book page 304" href="http://viewer.zmags.com/publication/b0929dae?page=304"> study, we did not see any response to BR salvage </a> <a title="EBMT Annual Meeting 2015 Absract Book page 305" href="http://viewer.zmags.com/publication/b0929dae?page=305"> analyzed. The evaluated possible prog</a> <a title="EBMT Annual Meeting 2015 Absract Book page 306" href="http://viewer.zmags.com/publication/b0929dae?page=306"> Conclusion: LLBL2001 protocol is capable of induc</a> <a title="EBMT Annual Meeting 2015 Absract Book page 307" href="http://viewer.zmags.com/publication/b0929dae?page=307"> 22%; EDAP 1, 1%), thalidomide-based (TD 15, 9%), </a> <a title="EBMT Annual Meeting 2015 Absract Book page 308" href="http://viewer.zmags.com/publication/b0929dae?page=308"> [P350] P351 Abstract</a> <a title="EBMT Annual Meeting 2015 Absract Book page 309" href="http://viewer.zmags.com/publication/b0929dae?page=309"> HSCT.MTX Þ Cyclosporine A were used as GVHD proph</a> <a title="EBMT Annual Meeting 2015 Absract Book page 310" href="http://viewer.zmags.com/publication/b0929dae?page=310"> bortezomib-based or lenalidomide-based) 143 pts u</a> <a title="EBMT Annual Meeting 2015 Absract Book page 311" href="http://viewer.zmags.com/publication/b0929dae?page=311"> a partial response, and two stable disease during</a> <a title="EBMT Annual Meeting 2015 Absract Book page 312" href="http://viewer.zmags.com/publication/b0929dae?page=312"> bendamustine 60mg/m2 on days 1 and 2, bortezomib </a> <a title="EBMT Annual Meeting 2015 Absract Book page 313" href="http://viewer.zmags.com/publication/b0929dae?page=313"> expression of the cytokine molecules as wel</a> <a title="EBMT Annual Meeting 2015 Absract Book page 314" href="http://viewer.zmags.com/publication/b0929dae?page=314"> (HR 12.362, Po0.001), and non-response to HMA (HR</a> <a title="EBMT Annual Meeting 2015 Absract Book page 315" href="http://viewer.zmags.com/publication/b0929dae?page=315"> CEBPA (8 pts; ms 5, fs 2, silent, sil, 1), DNMT3A</a> <a title="EBMT Annual Meeting 2015 Absract Book page 316" href="http://viewer.zmags.com/publication/b0929dae?page=316"> Presence of acute graft-versus-host disease (aGVH</a> <a title="EBMT Annual Meeting 2015 Absract Book page 317" href="http://viewer.zmags.com/publication/b0929dae?page=317"> 32%; range: 22-48; and IL-15: mean 53%; range 44-</a> <a title="EBMT Annual Meeting 2015 Absract Book page 318" href="http://viewer.zmags.com/publication/b0929dae?page=318"> Data collected included pt characteristics, biosi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 319" href="http://viewer.zmags.com/publication/b0929dae?page=319"> and TBI-based combinations. Definitive comparison </a> <a title="EBMT Annual Meeting 2015 Absract Book page 320" href="http://viewer.zmags.com/publication/b0929dae?page=320"> reduced-intensity conditioning (RIC) and allogeni</a> <a title="EBMT Annual Meeting 2015 Absract Book page 321" href="http://viewer.zmags.com/publication/b0929dae?page=321"> of patients, 4 escalating doses to a maxim</a> <a title="EBMT Annual Meeting 2015 Absract Book page 322" href="http://viewer.zmags.com/publication/b0929dae?page=322"> PHYSICIANS POSTER SESSIONS Poster session 2</a> <a title="EBMT Annual Meeting 2015 Absract Book page 323" href="http://viewer.zmags.com/publication/b0929dae?page=323"> allogeneic HSCT. In the current study </a> <a title="EBMT Annual Meeting 2015 Absract Book page 324" href="http://viewer.zmags.com/publication/b0929dae?page=324"> Materials (or patients) and methods: The reversib</a> <a title="EBMT Annual Meeting 2015 Absract Book page 325" href="http://viewer.zmags.com/publication/b0929dae?page=325"> morphology, phenotypic characteristics, tri-linea</a> <a title="EBMT Annual Meeting 2015 Absract Book page 326" href="http://viewer.zmags.com/publication/b0929dae?page=326"> DSCs following allogeneic hematopoietic stem cell</a> <a title="EBMT Annual Meeting 2015 Absract Book page 327" href="http://viewer.zmags.com/publication/b0929dae?page=327"> event attributable to TCL infusion was reco</a> <a title="EBMT Annual Meeting 2015 Absract Book page 328" href="http://viewer.zmags.com/publication/b0929dae?page=328"> cell therapy caused increase in muscle power and </a> <a title="EBMT Annual Meeting 2015 Absract Book page 329" href="http://viewer.zmags.com/publication/b0929dae?page=329"> Materials (or patients) and methods: 8 patients a</a> <a title="EBMT Annual Meeting 2015 Absract Book page 330" href="http://viewer.zmags.com/publication/b0929dae?page=330"> 1.5-2.0x109 TNC one might expect 1-2x106 Tregs. W</a> <a title="EBMT Annual Meeting 2015 Absract Book page 331" href="http://viewer.zmags.com/publication/b0929dae?page=331"> Results: Searches yielded 628 published </a> <a title="EBMT Annual Meeting 2015 Absract Book page 332" href="http://viewer.zmags.com/publication/b0929dae?page=332"> IL-2 R beta chain (CD122) was almost </a> <a title="EBMT Annual Meeting 2015 Absract Book page 333" href="http://viewer.zmags.com/publication/b0929dae?page=333"> formed an adherent layer in the dish. Microscopic</a> <a title="EBMT Annual Meeting 2015 Absract Book page 334" href="http://viewer.zmags.com/publication/b0929dae?page=334"> [P402] Mobilisation was su</a> <a title="EBMT Annual Meeting 2015 Absract Book page 335" href="http://viewer.zmags.com/publication/b0929dae?page=335"> [P403] in patients with mu</a> <a title="EBMT Annual Meeting 2015 Absract Book page 336" href="http://viewer.zmags.com/publication/b0929dae?page=336"> with age ranging from 18 to 77 years (median 50) </a> <a title="EBMT Annual Meeting 2015 Absract Book page 337" href="http://viewer.zmags.com/publication/b0929dae?page=337"> in etoposide group (P ¼ 0.035). Three patients in</a> <a title="EBMT Annual Meeting 2015 Absract Book page 338" href="http://viewer.zmags.com/publication/b0929dae?page=338"> P409 ``Plerixafor on-demand embedded with chemoth</a> <a title="EBMT Annual Meeting 2015 Absract Book page 339" href="http://viewer.zmags.com/publication/b0929dae?page=339"> (16 (7-43) days) and platelets (14 (6-56) </a> <a title="EBMT Annual Meeting 2015 Absract Book page 340" href="http://viewer.zmags.com/publication/b0929dae?page=340"> (ANGPT2), vascular endothelial growth factor (VEG</a> <a title="EBMT Annual Meeting 2015 Absract Book page 341" href="http://viewer.zmags.com/publication/b0929dae?page=341"> Currently, the most common praxis is to ad</a> <a title="EBMT Annual Meeting 2015 Absract Book page 342" href="http://viewer.zmags.com/publication/b0929dae?page=342"> P417 Negative depletion approaches of CD3 ab t ly</a> <a title="EBMT Annual Meeting 2015 Absract Book page 343" href="http://viewer.zmags.com/publication/b0929dae?page=343"> P419 Autologous peripheral blood stem cell transp</a> <a title="EBMT Annual Meeting 2015 Absract Book page 344" href="http://viewer.zmags.com/publication/b0929dae?page=344"> P421 Mobilization of autologous and allogeneic pe</a> <a title="EBMT Annual Meeting 2015 Absract Book page 345" href="http://viewer.zmags.com/publication/b0929dae?page=345"> (diabetes mellitus, hypertension and renal failur</a> <a title="EBMT Annual Meeting 2015 Absract Book page 346" href="http://viewer.zmags.com/publication/b0929dae?page=346"> autoHCST. We present results of a planned interim</a> <a title="EBMT Annual Meeting 2015 Absract Book page 347" href="http://viewer.zmags.com/publication/b0929dae?page=347"> a femoral access line was used. Larger blood volu</a> <a title="EBMT Annual Meeting 2015 Absract Book page 348" href="http://viewer.zmags.com/publication/b0929dae?page=348"> P429 Biosimilar filgrastim (Leucostims) seems to h</a> <a title="EBMT Annual Meeting 2015 Absract Book page 349" href="http://viewer.zmags.com/publication/b0929dae?page=349"> defined as ratio between the number of CD34 Þ cell</a> <a title="EBMT Annual Meeting 2015 Absract Book page 350" href="http://viewer.zmags.com/publication/b0929dae?page=350"> P434 PBSC mobilisation in children with metastati</a> <a title="EBMT Annual Meeting 2015 Absract Book page 351" href="http://viewer.zmags.com/publication/b0929dae?page=351"> recipient weight were recovered, the infusion of </a> <a title="EBMT Annual Meeting 2015 Absract Book page 352" href="http://viewer.zmags.com/publication/b0929dae?page=352"> P439 Situations affecting hematopoietic stem cell</a> <a title="EBMT Annual Meeting 2015 Absract Book page 353" href="http://viewer.zmags.com/publication/b0929dae?page=353"> P441 Does reinfusion of stem cell products in mul</a> <a title="EBMT Annual Meeting 2015 Absract Book page 354" href="http://viewer.zmags.com/publication/b0929dae?page=354"> late 2014. MNC combines continuous hard-spin cent</a> <a title="EBMT Annual Meeting 2015 Absract Book page 355" href="http://viewer.zmags.com/publication/b0929dae?page=355"> CD34 Þ -selection was performed by immunomagnetic</a> <a title="EBMT Annual Meeting 2015 Absract Book page 356" href="http://viewer.zmags.com/publication/b0929dae?page=356"> product; Po0.01] (Table 1) and therefore, C</a> <a title="EBMT Annual Meeting 2015 Absract Book page 357" href="http://viewer.zmags.com/publication/b0929dae?page=357"> (range, 17-80) after negative ab Þ T cell and CD</a> <a title="EBMT Annual Meeting 2015 Absract Book page 358" href="http://viewer.zmags.com/publication/b0929dae?page=358"> P451 Feasibility and advantages of a novel contin</a> <a title="EBMT Annual Meeting 2015 Absract Book page 359" href="http://viewer.zmags.com/publication/b0929dae?page=359"> Materials (or patients) and methods: This is a re</a> <a title="EBMT Annual Meeting 2015 Absract Book page 360" href="http://viewer.zmags.com/publication/b0929dae?page=360"> 13.5 (8-43) days from HSCT, respectively. M</a> <a title="EBMT Annual Meeting 2015 Absract Book page 361" href="http://viewer.zmags.com/publication/b0929dae?page=361"> The median yield of of CD 34 Þ cells </a> <a title="EBMT Annual Meeting 2015 Absract Book page 362" href="http://viewer.zmags.com/publication/b0929dae?page=362"> P460 ``On demand'' plerixafor as a mobilization r</a> <a title="EBMT Annual Meeting 2015 Absract Book page 363" href="http://viewer.zmags.com/publication/b0929dae?page=363"> Further studies are needed concerning number of i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 364" href="http://viewer.zmags.com/publication/b0929dae?page=364"> host disease. Here, we report our cen</a> <a title="EBMT Annual Meeting 2015 Absract Book page 365" href="http://viewer.zmags.com/publication/b0929dae?page=365"> Conclusion: Although in the past, the clini</a> <a title="EBMT Annual Meeting 2015 Absract Book page 366" href="http://viewer.zmags.com/publication/b0929dae?page=366"> was CR in 44%, with persistent disease in 55%. BM</a> <a title="EBMT Annual Meeting 2015 Absract Book page 367" href="http://viewer.zmags.com/publication/b0929dae?page=367"> Materials (or patients) and methods: Patients wit</a> <a title="EBMT Annual Meeting 2015 Absract Book page 368" href="http://viewer.zmags.com/publication/b0929dae?page=368"> indicator of transplantation success. Accordingly</a> <a title="EBMT Annual Meeting 2015 Absract Book page 369" href="http://viewer.zmags.com/publication/b0929dae?page=369"> Stem cell donor II P474 Allo-HSCT following RI</a> <a title="EBMT Annual Meeting 2015 Absract Book page 370" href="http://viewer.zmags.com/publication/b0929dae?page=370"> Conclusion: In this monocenter study cohort, the </a> <a title="EBMT Annual Meeting 2015 Absract Book page 371" href="http://viewer.zmags.com/publication/b0929dae?page=371"> P478 Mobilization of peripheral blood stem cells </a> <a title="EBMT Annual Meeting 2015 Absract Book page 372" href="http://viewer.zmags.com/publication/b0929dae?page=372"> P ¼ 0.03). Acute GVHD wasobserved at a rate of </a> <a title="EBMT Annual Meeting 2015 Absract Book page 373" href="http://viewer.zmags.com/publication/b0929dae?page=373"> Pre-existing health disorders were more frequent </a> <a title="EBMT Annual Meeting 2015 Absract Book page 374" href="http://viewer.zmags.com/publication/b0929dae?page=374"> Materials (or patients) and methods: </a> <a title="EBMT Annual Meeting 2015 Absract Book page 375" href="http://viewer.zmags.com/publication/b0929dae?page=375"> medical students at Mayo Medical School in </a> <a title="EBMT Annual Meeting 2015 Absract Book page 376" href="http://viewer.zmags.com/publication/b0929dae?page=376"> To reduce this number, we aim to enhance the regi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 377" href="http://viewer.zmags.com/publication/b0929dae?page=377"> P489 Natural Killer (NK) Cell And Natural Killer-</a> <a title="EBMT Annual Meeting 2015 Absract Book page 378" href="http://viewer.zmags.com/publication/b0929dae?page=378"> P491 Benefit of KIR alloreactivity based on recept</a> <a title="EBMT Annual Meeting 2015 Absract Book page 379" href="http://viewer.zmags.com/publication/b0929dae?page=379"> 5 and 6 with a total CD34 yield of 2.8 </a> <a title="EBMT Annual Meeting 2015 Absract Book page 380" href="http://viewer.zmags.com/publication/b0929dae?page=380"> administration. To enlarge the sample size, we ad</a> <a title="EBMT Annual Meeting 2015 Absract Book page 381" href="http://viewer.zmags.com/publication/b0929dae?page=381"> (MDS) need to be confirmed and the risk factors id</a> <a title="EBMT Annual Meeting 2015 Absract Book page 382" href="http://viewer.zmags.com/publication/b0929dae?page=382"> many hematological disorders. Successful immune r</a> <a title="EBMT Annual Meeting 2015 Absract Book page 383" href="http://viewer.zmags.com/publication/b0929dae?page=383"> Conclusion: We were able to generate immune-modul</a> <a title="EBMT Annual Meeting 2015 Absract Book page 384" href="http://viewer.zmags.com/publication/b0929dae?page=384"> particularly the ability of Treg treated DC</a> <a title="EBMT Annual Meeting 2015 Absract Book page 385" href="http://viewer.zmags.com/publication/b0929dae?page=385"> CsA (200ng/ml). Primed responders cells and mediu</a> <a title="EBMT Annual Meeting 2015 Absract Book page 386" href="http://viewer.zmags.com/publication/b0929dae?page=386"> confirmed before transplantation by high-d</a> <a title="EBMT Annual Meeting 2015 Absract Book page 387" href="http://viewer.zmags.com/publication/b0929dae?page=387"> Figure 1: The antigen processing and presentation</a> <a title="EBMT Annual Meeting 2015 Absract Book page 388" href="http://viewer.zmags.com/publication/b0929dae?page=388"> continued through wk 24. In non-responders (define</a> <a title="EBMT Annual Meeting 2015 Absract Book page 389" href="http://viewer.zmags.com/publication/b0929dae?page=389"> P516 Graft-Versus-Host Disease after Haploidentic</a> <a title="EBMT Annual Meeting 2015 Absract Book page 390" href="http://viewer.zmags.com/publication/b0929dae?page=390"> any grade. Serum concentrations of VEGF 4150 pg/m</a> <a title="EBMT Annual Meeting 2015 Absract Book page 391" href="http://viewer.zmags.com/publication/b0929dae?page=391"> incidence of transplant-related mortality was 11%</a> <a title="EBMT Annual Meeting 2015 Absract Book page 392" href="http://viewer.zmags.com/publication/b0929dae?page=392"> P522 Tolerance induction with post-transplantatio</a> <a title="EBMT Annual Meeting 2015 Absract Book page 393" href="http://viewer.zmags.com/publication/b0929dae?page=393"> PBSCT we designed, using unmanipulated PBSC with </a> <a title="EBMT Annual Meeting 2015 Absract Book page 394" href="http://viewer.zmags.com/publication/b0929dae?page=394"> Materials (or patients) and methods: Patient 1: S</a> <a title="EBMT Annual Meeting 2015 Absract Book page 395" href="http://viewer.zmags.com/publication/b0929dae?page=395"> was 53.2 years, 70% received URD transplants, and</a> <a title="EBMT Annual Meeting 2015 Absract Book page 396" href="http://viewer.zmags.com/publication/b0929dae?page=396"> Makoto Murata. A human minor histocompatibil</a> <a title="EBMT Annual Meeting 2015 Absract Book page 397" href="http://viewer.zmags.com/publication/b0929dae?page=397"> Materials (or patients) and methods: 6 micr</a> <a title="EBMT Annual Meeting 2015 Absract Book page 398" href="http://viewer.zmags.com/publication/b0929dae?page=398"> controls the innate immune cell and T-cell respon</a> <a title="EBMT Annual Meeting 2015 Absract Book page 399" href="http://viewer.zmags.com/publication/b0929dae?page=399"> Results: The outcome measures analyse</a> <a title="EBMT Annual Meeting 2015 Absract Book page 400" href="http://viewer.zmags.com/publication/b0929dae?page=400"> n ¼ 54) patients. The PAXgene Blood miRNA kit was</a> <a title="EBMT Annual Meeting 2015 Absract Book page 401" href="http://viewer.zmags.com/publication/b0929dae?page=401"> [P540] to ECP (SR vs. non </a> <a title="EBMT Annual Meeting 2015 Absract Book page 402" href="http://viewer.zmags.com/publication/b0929dae?page=402"> and TNF  reached statistical significance. After </a> <a title="EBMT Annual Meeting 2015 Absract Book page 403" href="http://viewer.zmags.com/publication/b0929dae?page=403"> myeloic leukemia or myelodisplastic syndrome </a> <a title="EBMT Annual Meeting 2015 Absract Book page 404" href="http://viewer.zmags.com/publication/b0929dae?page=404"> Table 1. Second line treatment response of sev</a> <a title="EBMT Annual Meeting 2015 Absract Book page 405" href="http://viewer.zmags.com/publication/b0929dae?page=405"> carriers of autoantigens and may play a ro</a> <a title="EBMT Annual Meeting 2015 Absract Book page 406" href="http://viewer.zmags.com/publication/b0929dae?page=406"> 1 or no aGvHD (P ¼ 0.041).We could not find any in</a> <a title="EBMT Annual Meeting 2015 Absract Book page 407" href="http://viewer.zmags.com/publication/b0929dae?page=407"> cGVHD. One patient started ECP 12 years after the</a> <a title="EBMT Annual Meeting 2015 Absract Book page 408" href="http://viewer.zmags.com/publication/b0929dae?page=408"> patients not exposed to statins. In additio</a> <a title="EBMT Annual Meeting 2015 Absract Book page 409" href="http://viewer.zmags.com/publication/b0929dae?page=409"> [P556] P557 Earlier dia</a> <a title="EBMT Annual Meeting 2015 Absract Book page 410" href="http://viewer.zmags.com/publication/b0929dae?page=410"> (CMV) reactivation. Despite the pre-emptive thera</a> <a title="EBMT Annual Meeting 2015 Absract Book page 411" href="http://viewer.zmags.com/publication/b0929dae?page=411"> P560 Comparison of characteristics of herpes zost</a> <a title="EBMT Annual Meeting 2015 Absract Book page 412" href="http://viewer.zmags.com/publication/b0929dae?page=412"> to approximately half a log less than</a> <a title="EBMT Annual Meeting 2015 Absract Book page 413" href="http://viewer.zmags.com/publication/b0929dae?page=413"> ADV viremia and disseminated disease were defined </a> <a title="EBMT Annual Meeting 2015 Absract Book page 414" href="http://viewer.zmags.com/publication/b0929dae?page=414"> Conclusion: To summarize, we found a statisticall</a> <a title="EBMT Annual Meeting 2015 Absract Book page 415" href="http://viewer.zmags.com/publication/b0929dae?page=415"> in primary prohylaxis. Although we did not observ</a> <a title="EBMT Annual Meeting 2015 Absract Book page 416" href="http://viewer.zmags.com/publication/b0929dae?page=416"> recipients. During the last few years the use of </a> <a title="EBMT Annual Meeting 2015 Absract Book page 417" href="http://viewer.zmags.com/publication/b0929dae?page=417"> Kingdom, 7CIC, IBMCC, Servicio General de Citomet</a> <a title="EBMT Annual Meeting 2015 Absract Book page 418" href="http://viewer.zmags.com/publication/b0929dae?page=418"> Without prophylaxis HSV disease after H</a> <a title="EBMT Annual Meeting 2015 Absract Book page 419" href="http://viewer.zmags.com/publication/b0929dae?page=419"> T-cells has been less clear, due the difficulty in</a> <a title="EBMT Annual Meeting 2015 Absract Book page 420" href="http://viewer.zmags.com/publication/b0929dae?page=420"> overall efficacy of the antivirals. Pati</a> <a title="EBMT Annual Meeting 2015 Absract Book page 421" href="http://viewer.zmags.com/publication/b0929dae?page=421"> 69 adults) and gB1gH1 (detected in 250 sam</a> <a title="EBMT Annual Meeting 2015 Absract Book page 422" href="http://viewer.zmags.com/publication/b0929dae?page=422"> 7 pts, often requiring systemic steroids. A</a> <a title="EBMT Annual Meeting 2015 Absract Book page 423" href="http://viewer.zmags.com/publication/b0929dae?page=423"> In 13 patients (48%) HHV-6 was considered as resp</a> <a title="EBMT Annual Meeting 2015 Absract Book page 424" href="http://viewer.zmags.com/publication/b0929dae?page=424"> we recently extended this clinical trial also to </a> <a title="EBMT Annual Meeting 2015 Absract Book page 425" href="http://viewer.zmags.com/publication/b0929dae?page=425"> It is also used in the management of neut</a> <a title="EBMT Annual Meeting 2015 Absract Book page 426" href="http://viewer.zmags.com/publication/b0929dae?page=426"> the late period post-ASCT are described in table </a> <a title="EBMT Annual Meeting 2015 Absract Book page 427" href="http://viewer.zmags.com/publication/b0929dae?page=427"> 8Pediatric Hematology/Oncology and BMT Unit, </a> <a title="EBMT Annual Meeting 2015 Absract Book page 428" href="http://viewer.zmags.com/publication/b0929dae?page=428"> intravenous doses of the letermovir cyclodextrin </a> <a title="EBMT Annual Meeting 2015 Absract Book page 429" href="http://viewer.zmags.com/publication/b0929dae?page=429"> [P597] stem cell</a> <a title="EBMT Annual Meeting 2015 Absract Book page 430" href="http://viewer.zmags.com/publication/b0929dae?page=430"> appropriate timing and that both u-CBT and haplo-</a> <a title="EBMT Annual Meeting 2015 Absract Book page 431" href="http://viewer.zmags.com/publication/b0929dae?page=431"> allowed visualization of significant interacti</a> <a title="EBMT Annual Meeting 2015 Absract Book page 432" href="http://viewer.zmags.com/publication/b0929dae?page=432"> [P603] divided into 3 grou</a> <a title="EBMT Annual Meeting 2015 Absract Book page 433" href="http://viewer.zmags.com/publication/b0929dae?page=433"> induces expansion of alloreactive T cells but its</a> <a title="EBMT Annual Meeting 2015 Absract Book page 434" href="http://viewer.zmags.com/publication/b0929dae?page=434"> [P607] (P ¼ </a> <a title="EBMT Annual Meeting 2015 Absract Book page 435" href="http://viewer.zmags.com/publication/b0929dae?page=435"> The % ratio of LS means (90% CI) followin</a> <a title="EBMT Annual Meeting 2015 Absract Book page 436" href="http://viewer.zmags.com/publication/b0929dae?page=436"> common side effect is graft-versus-host disease (</a> <a title="EBMT Annual Meeting 2015 Absract Book page 437" href="http://viewer.zmags.com/publication/b0929dae?page=437"> PO4^-3– ions diffuse to the epithelium interstiti</a> <a title="EBMT Annual Meeting 2015 Absract Book page 438" href="http://viewer.zmags.com/publication/b0929dae?page=438"> and hydronephrosis in the other. 1/12 had abdomin</a> <a title="EBMT Annual Meeting 2015 Absract Book page 439" href="http://viewer.zmags.com/publication/b0929dae?page=439"> significant predictive utility of QTD and QTcD for</a> <a title="EBMT Annual Meeting 2015 Absract Book page 440" href="http://viewer.zmags.com/publication/b0929dae?page=440"> admission were 28 and 22 days for allo-HCT and au</a> <a title="EBMT Annual Meeting 2015 Absract Book page 441" href="http://viewer.zmags.com/publication/b0929dae?page=441"> (n ¼ 5; HHV-6 limbic encephalitis, VZV meningo-en</a> <a title="EBMT Annual Meeting 2015 Absract Book page 442" href="http://viewer.zmags.com/publication/b0929dae?page=442"> who survive was 101 (61.2%) and 73 of these were </a> <a title="EBMT Annual Meeting 2015 Absract Book page 443" href="http://viewer.zmags.com/publication/b0929dae?page=443"> P624 Left ventricular systolic disfunction after </a> <a title="EBMT Annual Meeting 2015 Absract Book page 444" href="http://viewer.zmags.com/publication/b0929dae?page=444"> P626 Phase I study evaluating the pharmacokinetic</a> <a title="EBMT Annual Meeting 2015 Absract Book page 445" href="http://viewer.zmags.com/publication/b0929dae?page=445"> (CLS) and idiopathic pulmonary syndrome </a> <a title="EBMT Annual Meeting 2015 Absract Book page 446" href="http://viewer.zmags.com/publication/b0929dae?page=446"> survived for a minimum of 2 years after transplan</a> <a title="EBMT Annual Meeting 2015 Absract Book page 447" href="http://viewer.zmags.com/publication/b0929dae?page=447"> malignancy. A prospective study based on this new</a> <a title="EBMT Annual Meeting 2015 Absract Book page 448" href="http://viewer.zmags.com/publication/b0929dae?page=448"> P634 Increased risk for relapse if ATG are includ</a> <a title="EBMT Annual Meeting 2015 Absract Book page 449" href="http://viewer.zmags.com/publication/b0929dae?page=449"> patients were in CR (20 CR1 and 2 CR2) and 44 (67</a> <a title="EBMT Annual Meeting 2015 Absract Book page 450" href="http://viewer.zmags.com/publication/b0929dae?page=450"> The most common toxicity was mucositis (gradeZ3 i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 451" href="http://viewer.zmags.com/publication/b0929dae?page=451"> Conclusion: In conclusion, results of this prospe</a> <a title="EBMT Annual Meeting 2015 Absract Book page 452" href="http://viewer.zmags.com/publication/b0929dae?page=452"> [P642] opportunistic infections. T</a> <a title="EBMT Annual Meeting 2015 Absract Book page 453" href="http://viewer.zmags.com/publication/b0929dae?page=453"> AML after allo-HSCT (RIC versus MAC) are presente</a> <a title="EBMT Annual Meeting 2015 Absract Book page 454" href="http://viewer.zmags.com/publication/b0929dae?page=454"> P647 FEAM conditioning in Non Hodgkin/Hodgkin rel</a> <a title="EBMT Annual Meeting 2015 Absract Book page 455" href="http://viewer.zmags.com/publication/b0929dae?page=455"> cell disease (SCD) patients thereby avoiding</a> <a title="EBMT Annual Meeting 2015 Absract Book page 456" href="http://viewer.zmags.com/publication/b0929dae?page=456"> can not only up-modulate the tumor-associate</a> <a title="EBMT Annual Meeting 2015 Absract Book page 457" href="http://viewer.zmags.com/publication/b0929dae?page=457"> Results: The median follow-up was 54 months (rang</a> <a title="EBMT Annual Meeting 2015 Absract Book page 458" href="http://viewer.zmags.com/publication/b0929dae?page=458"> Se ¼ 0,56 at D100 and 1 at D200 for MFC) </a> <a title="EBMT Annual Meeting 2015 Absract Book page 459" href="http://viewer.zmags.com/publication/b0929dae?page=459"> a corresponding decrease in the CD4 Þ Th17</a> <a title="EBMT Annual Meeting 2015 Absract Book page 460" href="http://viewer.zmags.com/publication/b0929dae?page=460"> univariate regression models we analyzed SCT base</a> <a title="EBMT Annual Meeting 2015 Absract Book page 461" href="http://viewer.zmags.com/publication/b0929dae?page=461"> TCRab (median 815/mL range; 250-2185 vs 80/mL ran</a> <a title="EBMT Annual Meeting 2015 Absract Book page 462" href="http://viewer.zmags.com/publication/b0929dae?page=462"> both groups, CI-R was 0.17 in CC- and 0.4</a> <a title="EBMT Annual Meeting 2015 Absract Book page 463" href="http://viewer.zmags.com/publication/b0929dae?page=463"> interleukin 1 receptor domain containing ada</a> <a title="EBMT Annual Meeting 2015 Absract Book page 464" href="http://viewer.zmags.com/publication/b0929dae?page=464"> chimerism (n ¼ 87) within one year of HCT who wer</a> <a title="EBMT Annual Meeting 2015 Absract Book page 465" href="http://viewer.zmags.com/publication/b0929dae?page=465"> followed by autologous stem cell reinfusio</a> <a title="EBMT Annual Meeting 2015 Absract Book page 466" href="http://viewer.zmags.com/publication/b0929dae?page=466"> (IQR 0.7x103-1.57x106) and 218x103 (IQR 15.4</a> <a title="EBMT Annual Meeting 2015 Absract Book page 467" href="http://viewer.zmags.com/publication/b0929dae?page=467"> groups of TCD patients treated with different met</a> <a title="EBMT Annual Meeting 2015 Absract Book page 468" href="http://viewer.zmags.com/publication/b0929dae?page=468"> with a 10/10 matched unrelated donor. He was cond</a> <a title="EBMT Annual Meeting 2015 Absract Book page 469" href="http://viewer.zmags.com/publication/b0929dae?page=469"> tumour necrosis factor receptor p75 Fc </a> <a title="EBMT Annual Meeting 2015 Absract Book page 470" href="http://viewer.zmags.com/publication/b0929dae?page=470"> P682 Outcome of 29 patients with Wiskott-Aldrich </a> <a title="EBMT Annual Meeting 2015 Absract Book page 471" href="http://viewer.zmags.com/publication/b0929dae?page=471"> accounted for 18 (81,8%) of all white matter lesi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 472" href="http://viewer.zmags.com/publication/b0929dae?page=472"> anti-TcRab antibody followed by an anti-biot</a> <a title="EBMT Annual Meeting 2015 Absract Book page 473" href="http://viewer.zmags.com/publication/b0929dae?page=473"> patient (7%). Overall survival / d</a> <a title="EBMT Annual Meeting 2015 Absract Book page 474" href="http://viewer.zmags.com/publication/b0929dae?page=474"> P691 National Pediatric Hematopoietic Stem Cell T</a> <a title="EBMT Annual Meeting 2015 Absract Book page 475" href="http://viewer.zmags.com/publication/b0929dae?page=475"> observed (P4 0,05). We found that the our inciden</a> <a title="EBMT Annual Meeting 2015 Absract Book page 476" href="http://viewer.zmags.com/publication/b0929dae?page=476"> the first diagnostic tissue sample was used </a> <a title="EBMT Annual Meeting 2015 Absract Book page 477" href="http://viewer.zmags.com/publication/b0929dae?page=477"> identified as an extrinsic factor that supports th</a> <a title="EBMT Annual Meeting 2015 Absract Book page 478" href="http://viewer.zmags.com/publication/b0929dae?page=478"> Conclusion: High-dose fludarabine, targeted bu</a> <a title="EBMT Annual Meeting 2015 Absract Book page 479" href="http://viewer.zmags.com/publication/b0929dae?page=479"> treatment. The aim of this study was inves</a> <a title="EBMT Annual Meeting 2015 Absract Book page 480" href="http://viewer.zmags.com/publication/b0929dae?page=480"> Experimental stem cell transplantation P703 th</a> <a title="EBMT Annual Meeting 2015 Absract Book page 481" href="http://viewer.zmags.com/publication/b0929dae?page=481"> 19.0 (14.6-27.2), Po0.0001; CD56dim 2</a> <a title="EBMT Annual Meeting 2015 Absract Book page 482" href="http://viewer.zmags.com/publication/b0929dae?page=482"> Engraftment and growth kinetics of the human leuk</a> <a title="EBMT Annual Meeting 2015 Absract Book page 483" href="http://viewer.zmags.com/publication/b0929dae?page=483"> donors. The median number of transplanted CD34 st</a> <a title="EBMT Annual Meeting 2015 Absract Book page 484" href="http://viewer.zmags.com/publication/b0929dae?page=484"> Conclusion: IB route of PBSC tx if feasible, safe</a> <a title="EBMT Annual Meeting 2015 Absract Book page 485" href="http://viewer.zmags.com/publication/b0929dae?page=485"> Antibody-mediated effector functions were analyze</a> <a title="EBMT Annual Meeting 2015 Absract Book page 486" href="http://viewer.zmags.com/publication/b0929dae?page=486"> haploidentical 2nd allo-HSCT in 27%. 69% sh</a> <a title="EBMT Annual Meeting 2015 Absract Book page 487" href="http://viewer.zmags.com/publication/b0929dae?page=487"> regimen was used in 11 patients. The EMR localiza</a> <a title="EBMT Annual Meeting 2015 Absract Book page 488" href="http://viewer.zmags.com/publication/b0929dae?page=488"> relapse was observed in 6 patients and meningeal,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 489" href="http://viewer.zmags.com/publication/b0929dae?page=489"> P723 Stem cell transplantation from unrelated don</a> <a title="EBMT Annual Meeting 2015 Absract Book page 490" href="http://viewer.zmags.com/publication/b0929dae?page=490"> Materials (or patients) and methods: We ana</a> <a title="EBMT Annual Meeting 2015 Absract Book page 491" href="http://viewer.zmags.com/publication/b0929dae?page=491"> n ¼ 15) aged Z59 years with 59 pts aged Z66 years</a> <a title="EBMT Annual Meeting 2015 Absract Book page 492" href="http://viewer.zmags.com/publication/b0929dae?page=492"> P729 Sorafenib as a safe bridge to immunotherapy </a> <a title="EBMT Annual Meeting 2015 Absract Book page 493" href="http://viewer.zmags.com/publication/b0929dae?page=493"> significantly higher compared to lower PTSF </a> <a title="EBMT Annual Meeting 2015 Absract Book page 494" href="http://viewer.zmags.com/publication/b0929dae?page=494"> P732 Efficiency of hypomethylating agents after al</a> <a title="EBMT Annual Meeting 2015 Absract Book page 495" href="http://viewer.zmags.com/publication/b0929dae?page=495"> high, after adjusted the carbon monoxide diffusin</a> <a title="EBMT Annual Meeting 2015 Absract Book page 496" href="http://viewer.zmags.com/publication/b0929dae?page=496"> [P736] patients</a> <a title="EBMT Annual Meeting 2015 Absract Book page 497" href="http://viewer.zmags.com/publication/b0929dae?page=497"> (range 31-1180). Eleven patients out of 12 </a> <a title="EBMT Annual Meeting 2015 Absract Book page 498" href="http://viewer.zmags.com/publication/b0929dae?page=498"> pregnancy. The patient online forums are useful p</a> <a title="EBMT Annual Meeting 2015 Absract Book page 499" href="http://viewer.zmags.com/publication/b0929dae?page=499"> P742 Allogeneic Haematopoietic Stem Cell Transpla</a> <a title="EBMT Annual Meeting 2015 Absract Book page 500" href="http://viewer.zmags.com/publication/b0929dae?page=500"> course of the disease and immune reconstitution f</a> <a title="EBMT Annual Meeting 2015 Absract Book page 501" href="http://viewer.zmags.com/publication/b0929dae?page=501"> [P745] infusion</a> <a title="EBMT Annual Meeting 2015 Absract Book page 502" href="http://viewer.zmags.com/publication/b0929dae?page=502"> [P746] TKI-na¨ıve and 2G-TKI gro</a> <a title="EBMT Annual Meeting 2015 Absract Book page 503" href="http://viewer.zmags.com/publication/b0929dae?page=503"> Conclusion: Similarly to other published dat</a> <a title="EBMT Annual Meeting 2015 Absract Book page 504" href="http://viewer.zmags.com/publication/b0929dae?page=504"> Materials (or patients) and methods: All six allo</a> <a title="EBMT Annual Meeting 2015 Absract Book page 505" href="http://viewer.zmags.com/publication/b0929dae?page=505"> patients. Allogeneic haematopoietic stem cell tra</a> <a title="EBMT Annual Meeting 2015 Absract Book page 506" href="http://viewer.zmags.com/publication/b0929dae?page=506"> RBCs was determined by assessing the effects of h</a> <a title="EBMT Annual Meeting 2015 Absract Book page 507" href="http://viewer.zmags.com/publication/b0929dae?page=507"> [P757] response correla</a> <a title="EBMT Annual Meeting 2015 Absract Book page 508" href="http://viewer.zmags.com/publication/b0929dae?page=508"> P759 Abstract Withdrawn P760 The first case of </a> <a title="EBMT Annual Meeting 2015 Absract Book page 509" href="http://viewer.zmags.com/publication/b0929dae?page=509"> THE NURSES GROUP ORAL SESSIONS Oral Session</a> <a title="EBMT Annual Meeting 2015 Absract Book page 510" href="http://viewer.zmags.com/publication/b0929dae?page=510"> competencies and proficiencies, orientation for ne</a> <a title="EBMT Annual Meeting 2015 Absract Book page 511" href="http://viewer.zmags.com/publication/b0929dae?page=511"> effective as 10pm, and using Plerixafor pre-empti</a> <a title="EBMT Annual Meeting 2015 Absract Book page 512" href="http://viewer.zmags.com/publication/b0929dae?page=512"> 100-969). Patients had undergone myeloablativ</a> <a title="EBMT Annual Meeting 2015 Absract Book page 513" href="http://viewer.zmags.com/publication/b0929dae?page=513"> education, perceived barriers to discussing sexua</a> <a title="EBMT Annual Meeting 2015 Absract Book page 514" href="http://viewer.zmags.com/publication/b0929dae?page=514"> from the surveys included: `Not confined </a> <a title="EBMT Annual Meeting 2015 Absract Book page 515" href="http://viewer.zmags.com/publication/b0929dae?page=515"> N014 PARENTAL EXPERIENCES AND PERSPECTIVES OF END</a> <a title="EBMT Annual Meeting 2015 Absract Book page 516" href="http://viewer.zmags.com/publication/b0929dae?page=516"> discussion element. A number of themes have been </a> <a title="EBMT Annual Meeting 2015 Absract Book page 517" href="http://viewer.zmags.com/publication/b0929dae?page=517"> N019 BACK TO WORK AFTER ALLOGENEIC TRANSPLANT: EX</a> <a title="EBMT Annual Meeting 2015 Absract Book page 518" href="http://viewer.zmags.com/publication/b0929dae?page=518"> Oral Session 5 N021 AN OVERVIEW OF THE FRENCH </a> <a title="EBMT Annual Meeting 2015 Absract Book page 519" href="http://viewer.zmags.com/publication/b0929dae?page=519"> in the nutritional support, with the patient asse</a> <a title="EBMT Annual Meeting 2015 Absract Book page 520" href="http://viewer.zmags.com/publication/b0929dae?page=520"> N025 FOOD SECURITY FOR PARENTS OF PAEDIATRIC BONE</a> <a title="EBMT Annual Meeting 2015 Absract Book page 521" href="http://viewer.zmags.com/publication/b0929dae?page=521"> THE NURSES GROUP POSTER SESSION Nurse & Alli</a> <a title="EBMT Annual Meeting 2015 Absract Book page 522" href="http://viewer.zmags.com/publication/b0929dae?page=522"> NP003 FOLLOW-UP BY PHONE WITHIN 24 HOURS AFTER DI</a> <a title="EBMT Annual Meeting 2015 Absract Book page 523" href="http://viewer.zmags.com/publication/b0929dae?page=523"> Hodgkin lymphoma (NHL), and 61 (40%) were healthy</a> <a title="EBMT Annual Meeting 2015 Absract Book page 524" href="http://viewer.zmags.com/publication/b0929dae?page=524"> collaboration. The program is presently being ada</a> <a title="EBMT Annual Meeting 2015 Absract Book page 525" href="http://viewer.zmags.com/publication/b0929dae?page=525"> individual talks increase the patients/caregi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 526" href="http://viewer.zmags.com/publication/b0929dae?page=526"> systematizing information, developing a conti</a> <a title="EBMT Annual Meeting 2015 Absract Book page 527" href="http://viewer.zmags.com/publication/b0929dae?page=527"> Conclusion: DISCUSSION: BENEFITS  Nursing staf</a> <a title="EBMT Annual Meeting 2015 Absract Book page 528" href="http://viewer.zmags.com/publication/b0929dae?page=528"> improving. There has been a significant incr</a> <a title="EBMT Annual Meeting 2015 Absract Book page 529" href="http://viewer.zmags.com/publication/b0929dae?page=529"> and psychosocial aspects of patients with stem ce</a> <a title="EBMT Annual Meeting 2015 Absract Book page 530" href="http://viewer.zmags.com/publication/b0929dae?page=530"> The pain service is designed to reduce the need f</a> <a title="EBMT Annual Meeting 2015 Absract Book page 531" href="http://viewer.zmags.com/publication/b0929dae?page=531"> suspected neutropenic sepsis identified significant</a> <a title="EBMT Annual Meeting 2015 Absract Book page 532" href="http://viewer.zmags.com/publication/b0929dae?page=532"> NP029 TRANSFUSION SURVEILLANCE OF STEM CELL TRANS</a> <a title="EBMT Annual Meeting 2015 Absract Book page 533" href="http://viewer.zmags.com/publication/b0929dae?page=533"> Conclusion: These data have shown that the </a> <a title="EBMT Annual Meeting 2015 Absract Book page 534" href="http://viewer.zmags.com/publication/b0929dae?page=534"> company's recommended dosing schedule without neg</a> <a title="EBMT Annual Meeting 2015 Absract Book page 535" href="http://viewer.zmags.com/publication/b0929dae?page=535"> NP037 COMPARATIVE STUDY OF THE COLLECTION EFFICIE</a> <a title="EBMT Annual Meeting 2015 Absract Book page 536" href="http://viewer.zmags.com/publication/b0929dae?page=536"> - Four nurses expressed that the model enhanced a</a> <a title="EBMT Annual Meeting 2015 Absract Book page 537" href="http://viewer.zmags.com/publication/b0929dae?page=537"> [NP042] Results: Problem </a> <a title="EBMT Annual Meeting 2015 Absract Book page 538" href="http://viewer.zmags.com/publication/b0929dae?page=538"> Method: Here, nursing training program used at Ha</a> <a title="EBMT Annual Meeting 2015 Absract Book page 539" href="http://viewer.zmags.com/publication/b0929dae?page=539"> DIRECT. All of the clinical environment suc</a> <a title="EBMT Annual Meeting 2015 Absract Book page 540" href="http://viewer.zmags.com/publication/b0929dae?page=540"> NP049 THE DEVELOPMENT OF AN IN HOUSE TRANSPLANT S</a> <a title="EBMT Annual Meeting 2015 Absract Book page 541" href="http://viewer.zmags.com/publication/b0929dae?page=541"> legislation. SCT staff perceived an improvement i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 542" href="http://viewer.zmags.com/publication/b0929dae?page=542"> The results of this study create an awareness in </a> <a title="EBMT Annual Meeting 2015 Absract Book page 543" href="http://viewer.zmags.com/publication/b0929dae?page=543"> appointment with the paediatrician at every visit</a> <a title="EBMT Annual Meeting 2015 Absract Book page 544" href="http://viewer.zmags.com/publication/b0929dae?page=544"> We applied skin care based on the moist w</a> <a title="EBMT Annual Meeting 2015 Absract Book page 545" href="http://viewer.zmags.com/publication/b0929dae?page=545"> THE DATA MANAGEMENT GROUP Data Management </a> <a title="EBMT Annual Meeting 2015 Absract Book page 546" href="http://viewer.zmags.com/publication/b0929dae?page=546"> an overview of which data to be collected and als</a> <a title="EBMT Annual Meeting 2015 Absract Book page 547" href="http://viewer.zmags.com/publication/b0929dae?page=547"> Conclusion: HML 1.0 has been finalized and can be </a> <a title="EBMT Annual Meeting 2015 Absract Book page 548" href="http://viewer.zmags.com/publication/b0929dae?page=548"> response evaluation and reporting a measure </a> <a title="EBMT Annual Meeting 2015 Absract Book page 549" href="http://viewer.zmags.com/publication/b0929dae?page=549"> [P768] Figure 1. Model Com</a> <a title="EBMT Annual Meeting 2015 Absract Book page 550" href="http://viewer.zmags.com/publication/b0929dae?page=550"> THE QUALITY MANAGEMENT GROUP ORAL SESSION Qu</a> <a title="EBMT Annual Meeting 2015 Absract Book page 551" href="http://viewer.zmags.com/publication/b0929dae?page=551"> clear focus on the need for education and for dev</a> <a title="EBMT Annual Meeting 2015 Absract Book page 552" href="http://viewer.zmags.com/publication/b0929dae?page=552"> 3. Sto¨ rmer M, Wood EM, Schurig U, Karo </a> <a title="EBMT Annual Meeting 2015 Absract Book page 553" href="http://viewer.zmags.com/publication/b0929dae?page=553"> THE QUALITY MANAGEMENT GROUP POSTER SESSION </a> <a title="EBMT Annual Meeting 2015 Absract Book page 554" href="http://viewer.zmags.com/publication/b0929dae?page=554"> Conclusion: Countries with national certificat</a> <a title="EBMT Annual Meeting 2015 Absract Book page 555" href="http://viewer.zmags.com/publication/b0929dae?page=555"> Introduction: WMDA (World Marrow Donor </a> <a title="EBMT Annual Meeting 2015 Absract Book page 556" href="http://viewer.zmags.com/publication/b0929dae?page=556"> standard. At the same time, a survey based on the</a> <a title="EBMT Annual Meeting 2015 Absract Book page 557" href="http://viewer.zmags.com/publication/b0929dae?page=557"> cellular therapy products and lack of labor</a> <a title="EBMT Annual Meeting 2015 Absract Book page 558" href="http://viewer.zmags.com/publication/b0929dae?page=558"> infused (CD34 Þ 42x106/kg). Graft failure is ass</a> <a title="EBMT Annual Meeting 2015 Absract Book page 559" href="http://viewer.zmags.com/publication/b0929dae?page=559"> Results: Analysis of qualitative data i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 560" href="http://viewer.zmags.com/publication/b0929dae?page=560"> achieved in reducing the time of antibiotics admi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 561" href="http://viewer.zmags.com/publication/b0929dae?page=561"> STATISTICAL SYMPOSIUM ORAL PRESENTATIONS Sta</a> <a title="EBMT Annual Meeting 2015 Absract Book page 562" href="http://viewer.zmags.com/publication/b0929dae?page=562"> treat. A simple comparison of patients acco</a> <a title="EBMT Annual Meeting 2015 Absract Book page 563" href="http://viewer.zmags.com/publication/b0929dae?page=563"> PUBLICATION ONLY Cell therapy / cellular th</a> <a title="EBMT Annual Meeting 2015 Absract Book page 564" href="http://viewer.zmags.com/publication/b0929dae?page=564"> AB003 Untouched GMP-grade purified engineered immu</a> <a title="EBMT Annual Meeting 2015 Absract Book page 565" href="http://viewer.zmags.com/publication/b0929dae?page=565"> [AB005] Con</a> <a title="EBMT Annual Meeting 2015 Absract Book page 566" href="http://viewer.zmags.com/publication/b0929dae?page=566"> of: Cesca Therapeutics, Inc., J. Heiserman Employ</a> <a title="EBMT Annual Meeting 2015 Absract Book page 567" href="http://viewer.zmags.com/publication/b0929dae?page=567"> Over the years results of haploidentical tr</a> <a title="EBMT Annual Meeting 2015 Absract Book page 568" href="http://viewer.zmags.com/publication/b0929dae?page=568"> vomiting (12.4%) were found to be hig</a> <a title="EBMT Annual Meeting 2015 Absract Book page 569" href="http://viewer.zmags.com/publication/b0929dae?page=569"> Transfusion. 2010 Feb;50(2):501-6). The Vivostat </a> <a title="EBMT Annual Meeting 2015 Absract Book page 570" href="http://viewer.zmags.com/publication/b0929dae?page=570"> conditions a) alfa-Minimum Essential Medium </a> <a title="EBMT Annual Meeting 2015 Absract Book page 571" href="http://viewer.zmags.com/publication/b0929dae?page=571"> in this landscape. In addition to, diverse signal</a> <a title="EBMT Annual Meeting 2015 Absract Book page 572" href="http://viewer.zmags.com/publication/b0929dae?page=572"> The standard protocol for BM collection is </a> <a title="EBMT Annual Meeting 2015 Absract Book page 573" href="http://viewer.zmags.com/publication/b0929dae?page=573"> were applied other 28 patients for stem ce</a> <a title="EBMT Annual Meeting 2015 Absract Book page 574" href="http://viewer.zmags.com/publication/b0929dae?page=574"> and thrombocytes was 10 days in group 1, while in</a> <a title="EBMT Annual Meeting 2015 Absract Book page 575" href="http://viewer.zmags.com/publication/b0929dae?page=575"> Results presented in our studies suggest that col</a> <a title="EBMT Annual Meeting 2015 Absract Book page 576" href="http://viewer.zmags.com/publication/b0929dae?page=576"> level was 1.13±0.53/mL in period I, 34.9±8.52/mL </a> <a title="EBMT Annual Meeting 2015 Absract Book page 577" href="http://viewer.zmags.com/publication/b0929dae?page=577"> Whilst all selected cord unit pairs fulfilled nati</a> <a title="EBMT Annual Meeting 2015 Absract Book page 578" href="http://viewer.zmags.com/publication/b0929dae?page=578"> Results: All 64 allogeneic stem cell donors</a> <a title="EBMT Annual Meeting 2015 Absract Book page 579" href="http://viewer.zmags.com/publication/b0929dae?page=579"> transplantation (BMT) has been associated wi</a> <a title="EBMT Annual Meeting 2015 Absract Book page 580" href="http://viewer.zmags.com/publication/b0929dae?page=580"> Conclusion: We observe the same cGVHD incid</a> <a title="EBMT Annual Meeting 2015 Absract Book page 581" href="http://viewer.zmags.com/publication/b0929dae?page=581"> due to infections and three (13%) due to cGVHD. N</a> <a title="EBMT Annual Meeting 2015 Absract Book page 582" href="http://viewer.zmags.com/publication/b0929dae?page=582"> test). Similarly, the platelet content </a> <a title="EBMT Annual Meeting 2015 Absract Book page 583" href="http://viewer.zmags.com/publication/b0929dae?page=583"> procedures and was performed in three conse</a> <a title="EBMT Annual Meeting 2015 Absract Book page 584" href="http://viewer.zmags.com/publication/b0929dae?page=584"> AB046 Human metapneumovirus in haematopoetic stem</a> <a title="EBMT Annual Meeting 2015 Absract Book page 585" href="http://viewer.zmags.com/publication/b0929dae?page=585"> aminoglycosides and fluoroqionolones and r</a> <a title="EBMT Annual Meeting 2015 Absract Book page 586" href="http://viewer.zmags.com/publication/b0929dae?page=586"> kinetics of the viruses reactivation reflects the </a> <a title="EBMT Annual Meeting 2015 Absract Book page 587" href="http://viewer.zmags.com/publication/b0929dae?page=587"> Conclusion: Granulocyte transfusion might be an a</a> <a title="EBMT Annual Meeting 2015 Absract Book page 588" href="http://viewer.zmags.com/publication/b0929dae?page=588"> were included to study. HB-DNA levels were measur</a> <a title="EBMT Annual Meeting 2015 Absract Book page 589" href="http://viewer.zmags.com/publication/b0929dae?page=589"> retrospectively describes BMT complications</a> <a title="EBMT Annual Meeting 2015 Absract Book page 590" href="http://viewer.zmags.com/publication/b0929dae?page=590"> and ECOG (P ¼ 0.0009). High and median HCT </a> <a title="EBMT Annual Meeting 2015 Absract Book page 591" href="http://viewer.zmags.com/publication/b0929dae?page=591"> and trephine biopsy detected 10-20% infiltrat</a> <a title="EBMT Annual Meeting 2015 Absract Book page 592" href="http://viewer.zmags.com/publication/b0929dae?page=592"> Table Technical Aspects of Plasma Exchange and La</a> <a title="EBMT Annual Meeting 2015 Absract Book page 593" href="http://viewer.zmags.com/publication/b0929dae?page=593"> treatment The secondary malignancies may pre</a> <a title="EBMT Annual Meeting 2015 Absract Book page 594" href="http://viewer.zmags.com/publication/b0929dae?page=594"> steroids. 11 years after transplant she pre</a> <a title="EBMT Annual Meeting 2015 Absract Book page 595" href="http://viewer.zmags.com/publication/b0929dae?page=595"> Conclusion: The results show that all the tested </a> <a title="EBMT Annual Meeting 2015 Absract Book page 596" href="http://viewer.zmags.com/publication/b0929dae?page=596"> [AB075] AB076 Haematop</a> <a title="EBMT Annual Meeting 2015 Absract Book page 597" href="http://viewer.zmags.com/publication/b0929dae?page=597"> opioids. The data indicated that pain control det</a> <a title="EBMT Annual Meeting 2015 Absract Book page 598" href="http://viewer.zmags.com/publication/b0929dae?page=598"> ablative and reduced intensity conditioning </a> <a title="EBMT Annual Meeting 2015 Absract Book page 599" href="http://viewer.zmags.com/publication/b0929dae?page=599"> A different trend in overall survival and </a> <a title="EBMT Annual Meeting 2015 Absract Book page 600" href="http://viewer.zmags.com/publication/b0929dae?page=600"> consisting of treosulfan (36 mg/kg), </a> <a title="EBMT Annual Meeting 2015 Absract Book page 601" href="http://viewer.zmags.com/publication/b0929dae?page=601"> with PR/AD (100.0% vs. 35.7%; Fisher p-value: o0.</a> <a title="EBMT Annual Meeting 2015 Absract Book page 602" href="http://viewer.zmags.com/publication/b0929dae?page=602"> HFTBI group vs 20% in sTBI group (P ¼ n.s.).The C</a> <a title="EBMT Annual Meeting 2015 Absract Book page 603" href="http://viewer.zmags.com/publication/b0929dae?page=603"> Materials (or patients) and methods: Eighteen pat</a> <a title="EBMT Annual Meeting 2015 Absract Book page 604" href="http://viewer.zmags.com/publication/b0929dae?page=604"> sepsis in a patient with advanced ref</a> <a title="EBMT Annual Meeting 2015 Absract Book page 605" href="http://viewer.zmags.com/publication/b0929dae?page=605"> compared with bone marrow aspiration examination,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 606" href="http://viewer.zmags.com/publication/b0929dae?page=606"> Among patients with MC, we could identify: </a> <a title="EBMT Annual Meeting 2015 Absract Book page 607" href="http://viewer.zmags.com/publication/b0929dae?page=607"> Materials (or patients) and methods: </a> <a title="EBMT Annual Meeting 2015 Absract Book page 608" href="http://viewer.zmags.com/publication/b0929dae?page=608"> Results: Since Nov. 2011 monitoring MRD were perf</a> <a title="EBMT Annual Meeting 2015 Absract Book page 609" href="http://viewer.zmags.com/publication/b0929dae?page=609"> (GvHD) by infusion of cyclosporine, plus sh</a> <a title="EBMT Annual Meeting 2015 Absract Book page 610" href="http://viewer.zmags.com/publication/b0929dae?page=610"> 2.8 kg and his motor function was improved </a> <a title="EBMT Annual Meeting 2015 Absract Book page 611" href="http://viewer.zmags.com/publication/b0929dae?page=611"> depleted transplantation in combination with</a> <a title="EBMT Annual Meeting 2015 Absract Book page 612" href="http://viewer.zmags.com/publication/b0929dae?page=612"> Materials (or patients) and methods: A 15-months-</a> <a title="EBMT Annual Meeting 2015 Absract Book page 613" href="http://viewer.zmags.com/publication/b0929dae?page=613"> of graft in myeloid lineage. At the same time pla</a> <a title="EBMT Annual Meeting 2015 Absract Book page 614" href="http://viewer.zmags.com/publication/b0929dae?page=614"> evaluate the characteristics and the outcome of H</a> <a title="EBMT Annual Meeting 2015 Absract Book page 615" href="http://viewer.zmags.com/publication/b0929dae?page=615"> Materials (or patients) and methods: Between, Mar</a> <a title="EBMT Annual Meeting 2015 Absract Book page 616" href="http://viewer.zmags.com/publication/b0929dae?page=616"> with HIV infection who were initiated HAART and d</a> <a title="EBMT Annual Meeting 2015 Absract Book page 617" href="http://viewer.zmags.com/publication/b0929dae?page=617"> have been reported from Western countries, but on</a> <a title="EBMT Annual Meeting 2015 Absract Book page 618" href="http://viewer.zmags.com/publication/b0929dae?page=618"> survival (OS) median is 8,895 years and th</a> <a title="EBMT Annual Meeting 2015 Absract Book page 619" href="http://viewer.zmags.com/publication/b0929dae?page=619"> group of patients is 74 months (22-148). The long</a> <a title="EBMT Annual Meeting 2015 Absract Book page 620" href="http://viewer.zmags.com/publication/b0929dae?page=620"> immunophenotype were well balanced, 20 and 80% re</a> <a title="EBMT Annual Meeting 2015 Absract Book page 621" href="http://viewer.zmags.com/publication/b0929dae?page=621"> Materials (or patients) and methods: From 2004-20</a> <a title="EBMT Annual Meeting 2015 Absract Book page 622" href="http://viewer.zmags.com/publication/b0929dae?page=622"> AB134 Factors determining outcome of hematopoieti</a> <a title="EBMT Annual Meeting 2015 Absract Book page 623" href="http://viewer.zmags.com/publication/b0929dae?page=623"> Materials (or patients) and methods: 13-year</a> <a title="EBMT Annual Meeting 2015 Absract Book page 624" href="http://viewer.zmags.com/publication/b0929dae?page=624"> another patient, both responded well to gancyclov</a> <a title="EBMT Annual Meeting 2015 Absract Book page 625" href="http://viewer.zmags.com/publication/b0929dae?page=625"> Table 1. Clinical characteristics and follow u</a> <a title="EBMT Annual Meeting 2015 Absract Book page 626" href="http://viewer.zmags.com/publication/b0929dae?page=626"> AB143 Outcomes of allogeneic unrelated hematopoie</a> <a title="EBMT Annual Meeting 2015 Absract Book page 627" href="http://viewer.zmags.com/publication/b0929dae?page=627"> oligodendrocytes and Schwann cells and leading to</a> <a title="EBMT Annual Meeting 2015 Absract Book page 628" href="http://viewer.zmags.com/publication/b0929dae?page=628"> Although some of the herbs and their formulations</a> <a title="EBMT Annual Meeting 2015 Absract Book page 629" href="http://viewer.zmags.com/publication/b0929dae?page=629"> [AB148] Table 1. Patient characteristics, tr</a> <a title="EBMT Annual Meeting 2015 Absract Book page 630" href="http://viewer.zmags.com/publication/b0929dae?page=630"> tumor-free graft and possible graft-versus-lympho</a> <a title="EBMT Annual Meeting 2015 Absract Book page 631" href="http://viewer.zmags.com/publication/b0929dae?page=631"> showing normal CBC counts with persisting lymphoc</a> <a title="EBMT Annual Meeting 2015 Absract Book page 632" href="http://viewer.zmags.com/publication/b0929dae?page=632"> who are eligible for AHSCT. Given poor out</a> <a title="EBMT Annual Meeting 2015 Absract Book page 633" href="http://viewer.zmags.com/publication/b0929dae?page=633"> AB158 Hematopoietic stem cell transplantation for</a> <a title="EBMT Annual Meeting 2015 Absract Book page 634" href="http://viewer.zmags.com/publication/b0929dae?page=634"> induced febrile neutropenia (FN), were assessed i</a> <a title="EBMT Annual Meeting 2015 Absract Book page 635" href="http://viewer.zmags.com/publication/b0929dae?page=635"> Materials (or patients) and methods: 40 patients </a> <a title="EBMT Annual Meeting 2015 Absract Book page 636" href="http://viewer.zmags.com/publication/b0929dae?page=636"> AB164 Abstract Withdrawn AB165 Early versus del</a> <a title="EBMT Annual Meeting 2015 Absract Book page 637" href="http://viewer.zmags.com/publication/b0929dae?page=637"> chemotherapy is crucial for long term </a> <a title="EBMT Annual Meeting 2015 Absract Book page 638" href="http://viewer.zmags.com/publication/b0929dae?page=638"> Solid tumours AB170 High dose chemotherapy and</a> <a title="EBMT Annual Meeting 2015 Absract Book page 639" href="http://viewer.zmags.com/publication/b0929dae?page=639"> A N, A.G. AB138 A., U. O103 Aabdel gaffar, A.G. A</a> <a title="EBMT Annual Meeting 2015 Absract Book page 640" href="http://viewer.zmags.com/publication/b0929dae?page=640"> Ambruzova, Z. O038 Amendola, A. O032 Amer, N. P68</a> <a title="EBMT Annual Meeting 2015 Absract Book page 641" href="http://viewer.zmags.com/publication/b0929dae?page=641"> Bal, C. NP004, P028, P029, P288 Balan, A.M. P142,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 642" href="http://viewer.zmags.com/publication/b0929dae?page=642"> Beutel, G. P635 Beutels, P. P003 Bhatnagar, N. WP</a> <a title="EBMT Annual Meeting 2015 Absract Book page 643" href="http://viewer.zmags.com/publication/b0929dae?page=643"> Brune, M. O015, P110, P132, P751 Bruneau, J. </a> <a title="EBMT Annual Meeting 2015 Absract Book page 644" href="http://viewer.zmags.com/publication/b0929dae?page=644"> Chaminade, A. P486 Champ, D. P037, P159, P232</a> <a title="EBMT Annual Meeting 2015 Absract Book page 645" href="http://viewer.zmags.com/publication/b0929dae?page=645"> Crawley, C. P332, P561 Crazzolara, R. AB144 Crema</a> <a title="EBMT Annual Meeting 2015 Absract Book page 646" href="http://viewer.zmags.com/publication/b0929dae?page=646"> Diederichs, T. P599 Diedrich, H. P109, P635 Diens</a> <a title="EBMT Annual Meeting 2015 Absract Book page 647" href="http://viewer.zmags.com/publication/b0929dae?page=647"> Escolar, M. O074 Escrich, S. P445 Eser, A. P354 E</a> <a title="EBMT Annual Meeting 2015 Absract Book page 648" href="http://viewer.zmags.com/publication/b0929dae?page=648"> G., G. O103 Gaag, D. P539 Gaber, T. P303 Gabriel,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 649" href="http://viewer.zmags.com/publication/b0929dae?page=649"> Gonzalez-Mesones, B. P261 Gonza´ lez-Pardo, M. P0</a> <a title="EBMT Annual Meeting 2015 Absract Book page 650" href="http://viewer.zmags.com/publication/b0929dae?page=650"> Han, Q. P062 Han, T. O154 Han, T.-T. P603, P625 H</a> <a title="EBMT Annual Meeting 2015 Absract Book page 651" href="http://viewer.zmags.com/publication/b0929dae?page=651"> Huo, M.-R. O043 Hurlock, C. P141 Hurtado, A.M. O0</a> <a title="EBMT Annual Meeting 2015 Absract Book page 652" href="http://viewer.zmags.com/publication/b0929dae?page=652"> KAISARI, A. P077 Kaisari, K. P330 Kaiser, L. P671</a> <a title="EBMT Annual Meeting 2015 Absract Book page 653" href="http://viewer.zmags.com/publication/b0929dae?page=653"> Kliasova, G. O098 Klimczak, A. P052 Klimko, N. O0</a> <a title="EBMT Annual Meeting 2015 Absract Book page 654" href="http://viewer.zmags.com/publication/b0929dae?page=654"> Kwon, S.W. P408 Kyo, K. P629 Kyo, T. P629 Kyrcz-K</a> <a title="EBMT Annual Meeting 2015 Absract Book page 655" href="http://viewer.zmags.com/publication/b0929dae?page=655"> Liso, V. O001 Litzow, M. P396, P485 Liu, F. P594,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 656" href="http://viewer.zmags.com/publication/b0929dae?page=656"> Manko, J. P569 Mann, M. P048 Manna, N. O079 Manno</a> <a title="EBMT Annual Meeting 2015 Absract Book page 657" href="http://viewer.zmags.com/publication/b0929dae?page=657"> Mertlitz, S. P512 Messerle, M. O052 Messina, C. O</a> <a title="EBMT Annual Meeting 2015 Absract Book page 658" href="http://viewer.zmags.com/publication/b0929dae?page=658"> Mu¨ ller, L. P125 Mu¨ ller, L.P. P716 Mu¨ ller-Ti</a> <a title="EBMT Annual Meeting 2015 Absract Book page 659" href="http://viewer.zmags.com/publication/b0929dae?page=659"> Ongari, M. O106 Onida, F. O006, P091, P323, A</a> <a title="EBMT Annual Meeting 2015 Absract Book page 660" href="http://viewer.zmags.com/publication/b0929dae?page=660"> Pavesi, MD, F. O145 Pavic´ , N. P157 Pavletic, S.</a> <a title="EBMT Annual Meeting 2015 Absract Book page 661" href="http://viewer.zmags.com/publication/b0929dae?page=661"> Pouthier, F. P665 Pradier, A. P114, P671, P67</a> <a title="EBMT Annual Meeting 2015 Absract Book page 662" href="http://viewer.zmags.com/publication/b0929dae?page=662"> Rodrı´ guez-Raomanos, R. P529 Rodriguez-Salazar, </a> <a title="EBMT Annual Meeting 2015 Absract Book page 663" href="http://viewer.zmags.com/publication/b0929dae?page=663"> Sartorelli, O.C. P623 Sasmaz, I. AB044, AB061, AB</a> <a title="EBMT Annual Meeting 2015 Absract Book page 664" href="http://viewer.zmags.com/publication/b0929dae?page=664"> Shayegi, N. O023, P656 Shea, T. P640 Sheikh, S. P</a> <a title="EBMT Annual Meeting 2015 Absract Book page 665" href="http://viewer.zmags.com/publication/b0929dae?page=665"> Stelljes, M. O006, O023, O113, P637 Stelljes,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 666" href="http://viewer.zmags.com/publication/b0929dae?page=666"> Tiryaki, N. NP005, P028, P029, P288, P320 Tis</a> <a title="EBMT Annual Meeting 2015 Absract Book page 667" href="http://viewer.zmags.com/publication/b0929dae?page=667"> Vago, L. O016, O035, O140, O157, O160, P239,</a> <a title="EBMT Annual Meeting 2015 Absract Book page 668" href="http://viewer.zmags.com/publication/b0929dae?page=668"> Wang, W. P063 Wang, X.N. P383, P386, P387, P5</a> <a title="EBMT Annual Meeting 2015 Absract Book page 669" href="http://viewer.zmags.com/publication/b0929dae?page=669"> Yuan, A. P092 Yuan, H. P523, P524 Yuan, X. P699, </a>